<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1334" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1334/" /><meta name="ncbi_pagename" content="Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/03/02" /><meta name="citation_author" content="Ravikumar Balasubramanian" /><meta name="citation_author" content="William F Crowley, Jr" /><meta name="citation_pmid" content="20301509" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1334/" /><meta name="citation_keywords" content="Idiopathic Hypogonadotropic Hypogonadism" /><meta name="citation_keywords" content="Isolated Hypogonadotropic Hypogonadism" /><meta name="citation_keywords" content="Isolated Hypogonadotropic Hypogonadism" /><meta name="citation_keywords" content="Idiopathic Hypogonadotropic Hypogonadism" /><meta name="citation_keywords" content="Normosmic Isolated Gonadotropin-Releasing Hormone Deficiency" /><meta name="citation_keywords" content="Anosmin-1" /><meta name="citation_keywords" content="Chromodomain-helicase-DNA-binding protein 7" /><meta name="citation_keywords" content="Coiled-coil domain-containing protein 141" /><meta name="citation_keywords" content="DNA-directed RNA polymerase III subunit RPC2" /><meta name="citation_keywords" content="Dual specificity protein phosphatase 6" /><meta name="citation_keywords" content="Fez family zinc finger protein 1" /><meta name="citation_keywords" content="Fibroblast growth factor 17" /><meta name="citation_keywords" content="Fibroblast growth factor 8" /><meta name="citation_keywords" content="Fibroblast growth factor receptor 1" /><meta name="citation_keywords" content="Gonadotropin-releasing hormone receptor" /><meta name="citation_keywords" content="Heparan-sulfate 6-O-sulfotransferase 1" /><meta name="citation_keywords" content="Interleukin-17 receptor D" /><meta name="citation_keywords" content="KiSS-1 receptor" /><meta name="citation_keywords" content="Leucine-rich repeat transmembrane protein FLRT3" /><meta name="citation_keywords" content="Metastasis-suppressor KiSS-1" /><meta name="citation_keywords" content="Neuromedin-K receptor" /><meta name="citation_keywords" content="NMDA receptor synaptonuclear signaling and neuronal migration factor" /><meta name="citation_keywords" content="Progonadoliberin-1" /><meta name="citation_keywords" content="Prokineticin receptor 2" /><meta name="citation_keywords" content="Prokineticin-2" /><meta name="citation_keywords" content="Protein sprouty homolog 4" /><meta name="citation_keywords" content="Semaphorin-3A" /><meta name="citation_keywords" content="Semaphorin-3E" /><meta name="citation_keywords" content="Steroid receptor RNA activator 1" /><meta name="citation_keywords" content="Tachykinin-3" /><meta name="citation_keywords" content="Transcription factor SOX-10" /><meta name="citation_keywords" content="Tyrosine-protein kinase receptor UFO" /><meta name="citation_keywords" content="WD repeat-containing protein 11" /><meta name="citation_keywords" content="ANOS1" /><meta name="citation_keywords" content="AXL" /><meta name="citation_keywords" content="CCDC141" /><meta name="citation_keywords" content="CHD7" /><meta name="citation_keywords" content="DUSP6" /><meta name="citation_keywords" content="FEZF1" /><meta name="citation_keywords" content="FGF17" /><meta name="citation_keywords" content="FGF8" /><meta name="citation_keywords" content="FGFR1" /><meta name="citation_keywords" content="FLRT3" /><meta name="citation_keywords" content="GNRH1" /><meta name="citation_keywords" content="GNRHR" /><meta name="citation_keywords" content="HS6ST1" /><meta name="citation_keywords" content="IL17RD" /><meta name="citation_keywords" content="KISS1" /><meta name="citation_keywords" content="KISS1R" /><meta name="citation_keywords" content="NSMF" /><meta name="citation_keywords" content="POLR3B" /><meta name="citation_keywords" content="PROK2" /><meta name="citation_keywords" content="PROKR2" /><meta name="citation_keywords" content="SEMA3A" /><meta name="citation_keywords" content="SEMA3E" /><meta name="citation_keywords" content="SOX10" /><meta name="citation_keywords" content="SPRY4" /><meta name="citation_keywords" content="SRA1" /><meta name="citation_keywords" content="TAC3" /><meta name="citation_keywords" content="TACR3" /><meta name="citation_keywords" content="WDR11" /><meta name="citation_keywords" content="Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Ravikumar Balasubramanian" /><meta name="DC.Contributor" content="William F Crowley, Jr" /><meta name="DC.Date" content="2017/03/02" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1334/" /><meta name="description" content="Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., &lt;4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt." /><meta name="og:title" content="Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., &lt;4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1334/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/kms/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1334/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AD6C6E03F81210000000007BB029C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1334_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1334_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sca-io/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mma/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1334_"><span class="title" itemprop="name">Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Idiopathic Hypogonadotropic Hypogonadism, Isolated Hypogonadotropic Hypogonadism</div><p class="contrib-group"><span itemprop="author">Ravikumar Balasubramanian</span>, MD, PhD and <span itemprop="author">William F Crowley, Jr</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1334_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1334_ai__"><div class="contrib half_rhythm"><span itemprop="author">Ravikumar Balasubramanian</span>, MD, PhD<div class="affiliation small">Instructor, Harvard Medical School<br />Reproductive Endocrine Unit<br />Massachusetts General Hospital<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.srentrap@nainamarbusalabr" class="oemail">gro.srentrap@nainamarbusalabr</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">William F Crowley, Jr</span>, MD<div class="affiliation small">Professor of Medicine, Harvard Medical School<br />Chief, Reproductive Endocrine Unit of the<br />Department of Medicine<br />Massachusetts General Hospital<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.srentrap@yelworcw" class="oemail">gro.srentrap@yelworcw</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 23, 2007</span>; Last Update: <span itemprop="dateModified">March 2, 2017</span>.</p><p><em>Estimated reading time: 45 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="kms.Summary" itemprop="description"><h2 id="_kms_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., &#x0003c;4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>IGD is typically diagnosed in adolescents presenting with absent or partial puberty using biochemical testing that reveals low serum testosterone or estradiol (hypogonadism) that results from complete or partial absence of GnRH-mediated release of LH and FSH (hypogonadotropic hypogonadism [HH]) in the setting of otherwise normal anterior pituitary anatomy and function and in the absence of secondary causes of HH. Pathogenic variants in more than 25 genes account for about half of all IGD; the genetic cause for the remaining cases of IGD is unknown.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> To induce and maintain secondary sex characteristics, gradually increasing doses of testosterone or human chorionic gonadotropin (hCG) injections in males or estrogen and progestin in females; to stimulate spermatogenesis or folliculogenesis, either combined gonadotropin therapy (hCG and human menopausal gonadotropins [hMG] or recombinant FSH) or pulsatile GnRH therapy. If conception fails despite spermatogenesis in a male or ovulation induction in a female, in vitro fertilization may be an option.</p><p><i>Prevention of secondary complications:</i> Optimal calcium and vitamin D intake should be encouraged and specific treatment for decreased bone mass as needed.</p><p><i>Surveillance:</i> For children of both sexes with findings suggestive of IGD, monitor at regular intervals after age 11 years: sexual maturation (by Tanner staging on physical examination); gonadotropin and sex hormone levels; bone age. In individuals with confirmed IGD, monitor at regular intervals: serum sex steroid levels (to guide optimal hormone replacement); bone mineral density.</p><p><i>Evaluation of relatives at risk:</i> If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in a family are known, genetic testing of prepubertal at-risk relatives may be indicated to clarify their genetic status. Because of <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a>, a prepubertal child with a known pathogenic variant may progress through puberty in a normal or delayed fashion, or not at all; therefore, clinical reevaluation over time is necessary.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>IGD can be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Almost all IGD-related genes have also been associated with indeterminate or <a class="def" href="/books/n/gene/glossary/def-item/oligogenic/">oligogenic</a> inheritance. Recurrence risk counseling is based on family history and the results of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> when available. Carrier testing for at-risk relatives in families with X-linked IGD or autosomal recessive IGD is possible if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family are known. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant(s) in the family are known.</p></div></div><div id="kms.GeneReview_Scope"><h2 id="_kms_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="kms.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1334/table/kms.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kms.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kms.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Isolated Gonadotropin-Releasing Hormone Deficiency: Included Phenotypes</th></tr></thead><tbody><tr><td headers="hd_h_kms.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Normosmic <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> gonadotropin-releasing hormone deficiency</div></li><li class="half_rhythm"><div>Kallmann syndrome</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#kms.Nomenclature">Nomenclature</a>.</p></div></dd></dl></div></div></div></div><div id="kms.Diagnosis"><h2 id="_kms_Diagnosis_">Diagnosis</h2><p>Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) can be associated with a normal sense of smell (normosmic IGD) or an impaired sense of smell (Kallmann syndrome [KS]).</p><div id="kms.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) <b>should be suspected</b> in individuals with the following:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Absent or partial puberty</b>
<b>at presentation</b> in adolescents; low serum testosterone or estradiol on biochemical testing</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Findings of incomplete sexual maturation on physical examination</b> as determined by Tanner staging (see <a class="figpopup" href="/books/NBK1334/table/kms.T.tanner_staging/?report=objectonly" target="object" rid-figpopup="figkmsTtannerstaging" rid-ob="figobkmsTtannerstaging">Table 1</a>):</div><ul><li class="half_rhythm"><div>Men with IGD typically have Tanner stage I-II genitalia (prepubertal testicular volumes; i.e., &#x0003c;4 mL); however, some males show evidence of partial pubertal maturation [<a class="bk_pop" href="#kms.REF.pitteloud.2001.2470">Pitteloud et al 2001</a>].</div></li><li class="half_rhythm"><div>Women with IGD typically have Tanner stage I breast development and amenorrhea; however, some have spontaneous breast development and occasional menses [<a class="bk_pop" href="#kms.REF.shaw.2011.e566">Shaw et al 2011</a>].</div></li><li class="half_rhythm"><div>Both men and women with IGD typically have Tanner stage II-III pubic hair, since pubic hair is controlled in part by adrenal androgens.</div></li></ul><div class="half_rhythm">In rare males, IGD may present later in adulthood (i.e., adult-onset IGD). However, in these patients, as puberty was not disrupted, sexual maturation is complete and secondary sexual characteristics may be fully developed. Diagnosis of adult-onset IGD relies on documentation of hypogonadotropic hypogonadism (HH) and absence of other secondary causes of HH.</div></li></ul><ul><li class="half_rhythm"><div class="half_rhythm"><b>Laboratory findings of IGD</b> (see <a class="figpopup" href="/books/NBK1334/figure/kms.F1/?report=objectonly" target="object" rid-figpopup="figkmsF1" rid-ob="figobkmsF1">Figure 1</a> and <a class="figpopup" href="/books/NBK1334/figure/kms.F2/?report=objectonly" target="object" rid-figpopup="figkmsF2" rid-ob="figobkmsF2">Figure 2</a> for algorithm)</div><ul><li class="half_rhythm"><div>Total testosterone (T) &#x0003c;100 ng/dL in males and estradiol (E<sub>2</sub>) &#x0003c;50 pg/mL in females</div></li><li class="half_rhythm"><div>Inappropriately low or normal serum concentration of LH (luteinizing hormone) and FSH (follicle stimulating hormone) in the presence of low circulating concentrations of sex steroids. Levels of other anterior pituitary hormones are typically normal.</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>Imaging findings of IGD</b></div><ul><li class="half_rhythm"><div>In persons with IGD: typically, normal-appearing hypothalamus and pituitary on MRI exam</div></li><li class="half_rhythm"><div>In persons with KS: typically, aplasia or hypoplasia of the olfactory bulbs/sulci/tracts.</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>Olfactory findings.</b> Olfactory function is evaluated by history and by formal diagnostic smell tests, such as the University of Pennsylvania smell identification test (UPSIT), a "scratch and sniff" test that evaluates an individual's ability to identify 40 microencapsulated odorants and can be easily performed in most clinical settings [<a class="bk_pop" href="#kms.REF.doty.2007.460">Doty 2007</a>]. Anosmia, hyposmia, or normosmia is identified using the UPSIT manual normogram, which incorporates an individual&#x02019;s score, age at testing, and gender.</div><div class="half_rhythm">Individuals with IGD with either self-reported complete anosmia or a score of hyposmia/anosmia on UPSIT testing are diagnosed with KS, while those with normal olfactory function are diagnosed with normosmic IGD (nIGD) [<a class="bk_pop" href="#kms.REF.lewkowitzshpuntoff.2012.e136">Lewkowitz-Shpuntoff et al 2012</a>].</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figkmsF1" co-legend-rid="figlgndkmsF1"><a href="/books/NBK1334/figure/kms.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figkmsF1" rid-ob="figobkmsF1"><img class="small-thumb" src="/books/NBK1334/bin/kms-Image001.gif" src-large="/books/NBK1334/bin/kms-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndkmsF1"><h4 id="kms.F1"><a href="/books/NBK1334/figure/kms.F1/?report=objectonly" target="object" rid-ob="figobkmsF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Testing algorithm to establish the diagnosis of isolated GnRH deficiency (IGD) in males </p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figkmsF2" co-legend-rid="figlgndkmsF2"><a href="/books/NBK1334/figure/kms.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figkmsF2" rid-ob="figobkmsF2"><img class="small-thumb" src="/books/NBK1334/bin/kms-Image002.gif" src-large="/books/NBK1334/bin/kms-Image002.jpg" alt="Figure 2. " /></a><div class="icnblk_cntnt" id="figlgndkmsF2"><h4 id="kms.F2"><a href="/books/NBK1334/figure/kms.F2/?report=objectonly" target="object" rid-ob="figobkmsF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Testing algorithm to establish the diagnosis of isolated GnRH deficiency (IGD) in females </p></div></div><div id="kms.T.tanner_staging" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Tanner Staging</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1334/table/kms.T.tanner_staging/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kms.T.tanner_staging_lrgtbl__"><table><thead><tr><th id="hd_h_kms.T.tanner_staging_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_kms.T.tanner_staging_1_1_1_1" style="text-align:left;vertical-align:middle;">Stage</th><th id="hd_h_kms.T.tanner_staging_1_1_1_2" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Normal Findings</th></tr><tr><th headers="hd_h_kms.T.tanner_staging_1_1_1_2" id="hd_h_kms.T.tanner_staging_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Pubic Hair</th><th headers="hd_h_kms.T.tanner_staging_1_1_1_2" id="hd_h_kms.T.tanner_staging_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Male Genitalia</th><th headers="hd_h_kms.T.tanner_staging_1_1_1_2" id="hd_h_kms.T.tanner_staging_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Female Breast Development</th></tr></thead><tbody><tr><td headers="hd_h_kms.T.tanner_staging_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">I</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood appearance of testes, scrotum, and penis (testicular volume &#x0003c;4 mL)</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No breast bud, small areola, slight elevation of papilla</td></tr><tr><td headers="hd_h_kms.T.tanner_staging_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">II</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sparse hair that is long and slightly pigmented</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Enlargement of testes; reddish discoloration of scrotum</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Formation of the breast bud; areolar enlargement</td></tr><tr><td headers="hd_h_kms.T.tanner_staging_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">III</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Darker, coarser, curly hair</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Continued growth of testes and elongation of penis</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Continued growth of the breast bud and areola; areola confluent with breast</td></tr><tr><td headers="hd_h_kms.T.tanner_staging_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IV</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Adult hair covering pubis</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Continued growth of testes, widening of the penis with growth of the glans penis; scrotal darkening</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Continued growth; areola and papilla form secondary mound projecting above breast contour</td></tr><tr><td headers="hd_h_kms.T.tanner_staging_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">V</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Laterally distributed adult-type hair</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mature adult genitalia (testicular volume &#x0003e;15 mL)</td><td headers="hd_h_kms.T.tanner_staging_1_1_1_2 hd_h_kms.T.tanner_staging_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mature (areola again confluent with breast contour; only papilla projects)</td></tr></tbody></table></div></div></div><div id="kms.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of IGD <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> based on clinical and biochemical investigations <a href="#kms.Suggestive_Findings">above</a>; a genetic diagnosis can be made with identification of <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in one of the genes listed in <a class="figpopup" href="/books/NBK1334/table/kms.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figkmsTmoleculargenetictestingusedin" rid-ob="figobkmsTmoleculargenetictestingusedin">Table 2a</a> and <a class="figpopup" href="/books/NBK1334/table/kms.T.molecular_genetics_of_isolated_gon/?report=objectonly" target="object" rid-figpopup="figkmsTmoleculargeneticsofisolatedgon" rid-ob="figobkmsTmoleculargeneticsofisolatedgon">Table 2b</a>.</p><p>See <a class="figpopup" href="/books/NBK1334/table/kms.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figkmsTmoleculargenetictestingusedin" rid-ob="figobkmsTmoleculargenetictestingusedin">Table 2a</a> for the most common genetic causes (i.e., pathogenic variants of any one of the genes included in this table account for &#x0003e;2% of IGD) and <a class="figpopup" href="/books/NBK1334/table/kms.T.molecular_genetics_of_isolated_gon/?report=objectonly" target="object" rid-figpopup="figkmsTmoleculargeneticsofisolatedgon" rid-ob="figobkmsTmoleculargeneticsofisolatedgon">Table 2b</a> for less common genetic causes (i.e., pathogenic variants of any one of the genes included in this table are reported in only a few families).</p><p>Molecular testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> can be considered based on <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> and clinical findings, especially non-reproductive phenotypic features that indicate that pathogenic variation of a particular gene is most likely. Sequence analysis of the gene of interest is performed first, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</p><p>To help prioritize the order of serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing, the following can be considered (see <a class="figpopup" href="/books/NBK1334/figure/kms.F3/?report=objectonly" target="object" rid-figpopup="figkmsF3" rid-ob="figobkmsF3">Figure 3</a> and <a class="figpopup" href="/books/NBK1334/figure/kms.F4/?report=objectonly" target="object" rid-figpopup="figkmsF4" rid-ob="figobkmsF4">Figure 4</a>):</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figkmsF3" co-legend-rid="figlgndkmsF3"><a href="/books/NBK1334/figure/kms.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figkmsF3" rid-ob="figobkmsF3"><img class="small-thumb" src="/books/NBK1334/bin/kms-Image003.gif" src-large="/books/NBK1334/bin/kms-Image003.jpg" alt="Figure 3. " /></a><div class="icnblk_cntnt" id="figlgndkmsF3"><h4 id="kms.F3"><a href="/books/NBK1334/figure/kms.F3/?report=objectonly" target="object" rid-ob="figobkmsF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">Genes associated with isolated GnRH deficiency (IGD) by sense of smell and mode of inheritance </p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figkmsF4" co-legend-rid="figlgndkmsF4"><a href="/books/NBK1334/figure/kms.F4/?report=objectonly" target="object" title="Figure 4. " class="img_link icnblk_img figpopup" rid-figpopup="figkmsF4" rid-ob="figobkmsF4"><img class="small-thumb" src="/books/NBK1334/bin/kms-Image004.gif" src-large="/books/NBK1334/bin/kms-Image004.jpg" alt="Figure 4. " /></a><div class="icnblk_cntnt" id="figlgndkmsF4"><h4 id="kms.F4"><a href="/books/NBK1334/figure/kms.F4/?report=objectonly" target="object" rid-ob="figobkmsF4">Figure 4. </a></h4><p class="float-caption no_bottom_margin">Suggested guidelines for prioritization of genetic testing for persons with IGD based on phenotype [modified from Au et al 2011] </p></div></div><ul><li class="half_rhythm"><div><b>Sense of smell</b></div><ul><li class="half_rhythm"><div>Pathogenic variants in <i>CHD7</i>, <i>FGF8</i>, <i>FGF17</i>, <i>FGFR1</i>, <i>HS6ST1</i>, <i>NSMF</i> (<i>NELF</i>), <i>PROK2</i>, <i>PROKR2</i>, and <i>WDR11</i> cause both Kallmann syndrome (KS) and normosmic IGD (nIGD).</div></li><li class="half_rhythm"><div>Pathogenic variants in <i>ANOS1</i> (<i>KAL1</i>), <i>CCDC141</i>, <i>FEZF1</i>, <i>IL17RD</i>, <i>SEMA3A</i>, <i>SEMA3E</i>, and <i>SOX10</i> cause KS.</div></li><li class="half_rhythm"><div>Pathogenic variants in <i>GNRH1</i>, <i>GNRHR</i>, <i>KISS1</i>, <i>KISS1R</i> (<i>GPR54</i>), <i>TAC3</i>, and <i>TACR3</i> cause nIGD.</div></li></ul></li><li class="half_rhythm"><div><b>Mode of inheritance</b></div><ul><li class="half_rhythm"><div><b><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>.</b> Sequence analysis of <i>ANOS1</i> (<i>KAL1</i>) is the highest-yield molecular genetic test.</div></li><li class="half_rhythm"><div><b>Autosomal dominant.</b> In families with clear <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance, testing of <i>CHD7, FGFR1, FGF8</i> and <i>SOX10</i> can be considered.</div></li><li class="half_rhythm"><div><b>Autosomal recessive.</b> Testing of <i>GNRH1</i>, <i>GNRHR</i>, <i>KISS1</i>, <i>KISS1R</i>, <i>TAC3</i>, and <i>TACR3</i> can be considered in families with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> normosmic IGD; testing of <i>FEZF1</i>, <i>PROK2</i> and <i>PROKR2</i> can be considered in families with autosomal recessive KS.</div></li></ul></li><li class="half_rhythm"><div><b>Associated phenotypic features.</b> The presence of some associated clinical phenotypic features may also help prioritize genetic testing in IGD [<a class="bk_pop" href="#kms.REF.costabarbosa.2013.e943">Costa-Barbosa et al 2013</a>]. See <a class="figpopup" href="/books/NBK1334/figure/kms.F4/?report=objectonly" target="object" rid-figpopup="figkmsF4" rid-ob="figobkmsF4">Figure 4</a>.</div></li></ul><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes the genes listed in <a class="figpopup" href="/books/NBK1334/table/kms.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figkmsTmoleculargenetictestingusedin" rid-ob="figobkmsTmoleculargenetictestingusedin">Table 2a</a> and <a class="figpopup" href="/books/NBK1334/table/kms.T.molecular_genetics_of_isolated_gon/?report=objectonly" target="object" rid-figpopup="figkmsTmoleculargeneticsofisolatedgon" rid-ob="figobkmsTmoleculargeneticsofisolatedgon">Table 2b</a> and other genes of interest (see <a href="#kms.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. This should be the first step when the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has no clearly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members and/or no associated phenotypic features. Note: The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="kms.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 2a. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency: Most Common Genetic Causes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1334/table/kms.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kms.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">% of IGD Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>3</sup></th><th id="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>4</sup> Detected by Test Method</th></tr><tr><th headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>5</sup></th><th headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></th></tr></thead><tbody><tr><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ANOS1</i> (<i>KAL1</i>)</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%-10% (KS)</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~88%-99%</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;12% in one study (4/33 persons w/KS)&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHD7</i></td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%-10% (KS or nIGD)</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR1</i></td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~10% (KS or nIGD)</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GNRHR</i></td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%-10% (nIGD)</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IL17RD</i></td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2%-5% (KS or nIGD)</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PROKR2</i></td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~5% (KS or nIGD)</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown<sup>8</sup></td></tr><tr><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SOX10</i></td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2%-5% (KS)</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TACR3</i></td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~5% (nIGD)</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td><td headers="hd_h_kms.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_kms.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Pathogenic variants of any one of the genes included in this table account for &#x0003e;2% of IGD.</p></div></dd><dt></dt><dd><div><p class="no_margin">KS = Kallmann syndrome; nIGD = normosmic <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> gonadotropin-releasing hormone deficiency</p></div></dd><dt>1. </dt><dd><div id="kms.TF.2a.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="kms.TF.2a.2"><p class="no_margin">See <a href="/books/NBK1334/#kms.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="kms.TF.2a.3"><p class="no_margin">Proportion of IGD attributed to these genes is determined from the author&#x02019;s cohort of 950 probands with IGD who were screened for rare sequence variants (&#x0003c;1% of control cohort).</p></div></dd><dt>4. </dt><dd><div id="kms.TF.2a.4"><p class="no_margin">See <a href="#kms.Molecular_Genetics">Molecular Genetics</a> for information on pathogenic allelic variants detected.</p></div></dd><dt>5. </dt><dd><div id="kms.TF.2a.5"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>6. </dt><dd><div id="kms.TF.2a.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="kms.TF.2a.7"><p class="no_margin">12% of persons with KS harbored intragenic deletions in <i>ANOS1</i> [<a class="bk_pop" href="#kms.REF.pedersenwhite.2008.367">Pedersen-White et al 2008</a>].</p></div></dd><dt>8. </dt><dd><div id="kms.TF.2a.8"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>9. </dt><dd><div id="kms.TF.2a.9"><p class="no_margin"><i>FGFR1</i> deletions are rare [<a class="bk_pop" href="#kms.REF.trarbach.2010b.371">Trarbach et al 2010b</a>].</p></div></dd></dl></div></div></div><div id="kms.T.molecular_genetics_of_isolated_gon" class="table"><h3><span class="label">Table 2b. </span></h3><div class="caption"><p>Molecular Genetics of Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency: Less Common Genetic Causes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1334/table/kms.T.molecular_genetics_of_isolated_gon/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kms.T.molecular_genetics_of_isolated_gon_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2,&#x000a0;3</sup></th><th id="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comments</th><th id="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th></tr></thead><tbody><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AXL</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Described in 1 report: 4/104 persons w/KS or nIGD</td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.salianmehta.2014.1452">Salian-Mehta et al [2014]</a></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CCDC141</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Described in 1 report: 1/20 persons w/KS</td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.hutchins.2016.1956">Hutchins et al [2016]</a></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DUSP6</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Described in 1 report: 5/386 persons w/KS or nIGD</td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.miraoui.2013.725">Miraoui et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FEZF1</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Described in 1 report: 2/30 persons w/KS</td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.kotan.2014.326">Kotan et al [2014]</a></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGF8</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;2%&#x000a0;<sup>4</sup> of persons w/KS or nIGD</td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGF17</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Described in 1 report: 3/386 persons w/KS or nIGD</td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.miraoui.2013.725">Miraoui et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FLRT3</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Described in 1 report: 3/386 persons w/KS or nIGD</td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.miraoui.2013.725">Miraoui et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GNRH1</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically AR; &#x0003c;2%&#x000a0;<sup>4</sup> of persons w/nIGD</td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HS6ST1</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;2% of persons w/KS or nIGD&#x000a0;<sup>4,&#x000a0;5</sup></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KISS1</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically AR; &#x0003c;2% of persons w/nIGD&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KISS1R</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically AR; &#x0003c;2% of persons w/nIGD&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POLR3B</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Described in 1 report: 3/565 persons w/KS or nIGD</td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.richards.2017.19">Richards et al [2017]</a></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PROK2</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically AR; &#x0003c;2%&#x000a0;<sup>4</sup> of persons w/KS or nIGD&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SEMA3A</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;2% of persons w/KS or nIGD&#x000a0;<sup>4,&#x000a0;5</sup></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SEMA3E</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Described in 1 report: 1/121 persons w/KS or nIGD</td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.cariboni.2015.2413">Cariboni et al [2015]</a></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPRY4</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Described in 1 report: 14/386 persons w/KS or nIGD</td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.miraoui.2013.725">Miraoui et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SRA1</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Described in 1 report: 3/136 persons w/nIGD</td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.kotan.2016.125">Kotan et al [2016]</a></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TAC3</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically AR; &#x0003c;2% of persons w/nIGD&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WDR11</i></td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Described in 1 report: 1 person w/balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>; 6/201 persons w/KS or nIGD</td><td headers="hd_h_kms.T.molecular_genetics_of_isolated_gon_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.kim.2010.465">Kim et al [2010]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Pathogenic variants of any one of the genes listed in this table are reported in only a few families (i.e., &#x0003c;2% of IGD)</p></div></dd><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; KS = Kallmann syndrome; nIGD = normosmic <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> gonadotropin-releasing hormone deficiency</p></div></dd><dt>1. </dt><dd><div id="kms.TF.2b.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="kms.TF.2b.2"><p class="no_margin">See <a href="/books/NBK1334/#kms.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="kms.TF.2b.3"><p class="no_margin">Genes are not described in detail in Molecular Genetics but may be included <a href="/books/NBK1334/bin/kms-less_common_genes.pdf">here</a> (pdf).</p></div></dd><dt>4. </dt><dd><div id="kms.TF.2b.4"><p class="no_margin">Proportion of IGD attributed to these genes is determined from the author&#x02019;s cohort of 950 probands with IGD who were screened for rare sequence variants (&#x0003c;1% of control cohort).</p></div></dd><dt>5. </dt><dd><div id="kms.TF.2b.5"><p class="no_margin">Pathogenic variants in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> are not thought to cause IGD without contributions from other IGD-related genes; thus, the proportion of IGD caused by pathogenic variants in this gene is unknown.</p></div></dd></dl></div></div></div></div></div><div id="kms.Clinical_Characteristics"><h2 id="_kms_Clinical_Characteristics_">Clinical Characteristics</h2><div id="kms.Clinical_Description"><h3>Clinical Description</h3><p>The clinical manifestations of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> GnRH deficiency (IGD) depend on the stage of development at which the deficiency in the reproductive axis first occurred &#x02013; in infancy, adolescence, or (rarely) adulthood. Most individuals with IGD are identified at puberty; however, suggestive clinical features may be present in infancy.</p><div id="kms.Reproductive_Phenotype"><h4>Reproductive Phenotype</h4><p><b>Infancy.</b> Microphallus (stretched penile length &#x0003c;1.9 cm in a full-term newborn male) and cryptorchidism (undescended testes) represent two early clinical findings that may be present in male infants with IGD, although the significance of these findings is usually not recognized until puberty. Both clinical features reflect <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> GnRH deficiency and, if measured in male infants, concentrations of testosterone, LH (luteinizing hormone), and FSH (follicle stimulating hormone) are low in the first six months of life in these infants (neonatal window) [<a class="bk_pop" href="#kms.REF.grumbach.2005.3122">Grumbach 2005</a>].</p><p>Although microphallus and cryptorchidism can occur in both forms of IGD (KS and normosmic IGD), these features are more common in males with KS than in those with normosmic IGD [<a class="bk_pop" href="#kms.REF.pitteloud.2002a.152">Pitteloud et al 2002a</a>].</p><p>Female infants typically do not exhibit any clinical features that may indicate IGD.</p><p><b>Adolescence.</b> At puberty, most individuals with IGD have abnormal sexual maturation, usually with incomplete development of secondary sexual characteristics. However, the degree to which sexual maturation is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> can vary (see <b>Fertile hypogonadal variant of IGD in males</b>).</p><p>Males with IGD typically have prepubertal testicular volume (i.e., &#x0003c;4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth and deepening of the voice), and decreased muscle mass.</p><p>Females with IGD typically have little or no breast development and primary amenorrhea, but milder presentations with spontaneous menses are recognized [<a class="bk_pop" href="#kms.REF.shaw.2011.e566">Shaw et al 2011</a>].</p><p>Since adrenal maturation proceeds normally, the low levels of androgens produced in the adrenal glands may be sufficient for normal onset of pubic hair growth (adrenarche) in both sexes.</p><p>Because of the failure of growth plates in the bone to fuse in the absence of sex hormones, most individuals with IGD, both males and females may have disproportionate arm span compared to height (arm span typically exceeds height by &#x02265;5 cm). Whereas skeletal maturation is delayed, the rate of linear growth is usually normal (save for the absence of a distinct pubertal growth spurt) [<a class="bk_pop" href="#kms.REF.van_dop.1987.684">Van Dop et al 1987</a>].</p><p><b>Fertile hypogonadal variant of IGD in males.</b> Some degree of pubertal development can occur in some individuals with IGD. The relatively mildest form of abnormal pubertal development is found in males who have clinical evidence of hypogonadism with low serum concentration of testosterone but evidence of partial pubertal development with normal or near-normal testicular volumes, normal levels of inhibin B (the seminiferous tubular secretory protein), and, often, sperm in their ejaculate.</p><p><b>Reversal</b> of IGD, defined as restoration of normal serum testosterone concentrations after cessation of even brief treatment with sex steroid, gonadotropin, or GnRH, occurs in about 10% of all men with IGD, including those with KS [<a class="bk_pop" href="#kms.REF.raivio.2007.863">Raivio et al 2007</a>, <a class="bk_pop" href="#kms.REF.sidhoum.2014.861">Sidhoum et al 2014</a>]. This post-treatment &#x0201c;awakening&#x0201d; of the hypothalamo-pituitary-gonadal (HPG) axis suggests the presence of hypothalamic GnRH neurons that do not function during adolescence and possibly require hitherto undefined stimuli (potentially environmental/sex steroid exposure) to initiate normal activity. The precise physiologic basis of the reversal phenomenon is yet to be fully understood.</p></div><div id="kms.Olfactory_Phenotype"><h4>Olfactory Phenotype</h4><p><b>Anosmia.</b> The impaired olfactory function in Kallmann syndrome can be either hyposmia or complete anosmia) [<a class="bk_pop" href="#kms.REF.bianco.2009.569">Bianco &#x00026; Kaiser 2009</a>]. The difference between hyposmia and anosmia is quantitative and not qualitative (i.e., odorants can be variably <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> in persons with hyposmia). Most individuals with impaired smell do not have any physical or social impairment and the finding often goes unnoticed until IGD is diagnosed.</p></div><div id="kms.Reproductive_and_NonReproductive_Phe"><h4>Reproductive and Non-Reproductive Phenotypes by Gene</h4><p><a class="figpopup" href="/books/NBK1334/table/kms.T.isolated_gnrh_deficiency_igd_pheno/?report=objectonly" target="object" rid-figpopup="figkmsTisolatedgnrhdeficiencyigdpheno" rid-ob="figobkmsTisolatedgnrhdeficiencyigdpheno">Table 3</a> summarizes by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> the scope of the reproductive defect, olfactory function, and non-reproductive issues.</p><div id="kms.T.isolated_gnrh_deficiency_igd_pheno" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Isolated GnRH Deficiency (IGD) Phenotype by Gene</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1334/table/kms.T.isolated_gnrh_deficiency_igd_pheno/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kms.T.isolated_gnrh_deficiency_igd_pheno_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Phenotypic Features</th><th id="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" style="text-align:left;vertical-align:middle;">References</th></tr><tr><th headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2" id="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Reproductive</th><th headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2" id="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Olfactory</th><th headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2" id="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other Non-Reproductive</th></tr></thead><tbody><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ANOS1</i> (<i>KAL1</i>)&#x000a0;<sup>1,&#x000a0;2</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD (males)</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or hyposmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Digital synkinesia (in ~80% males)</div></li><li class="half_rhythm"><div>Unilateral renal agenesis (in ~30% males)&#x000a0;<sup>3</sup></div></li><li class="half_rhythm"><div>High-arched palate</div></li></ul>
</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.oliveira.2001.1532">Oliveira et al [2001]</a>, <a class="bk_pop" href="#kms.REF.quinton.2001.163">Quinton et al [2001]</a>, <a class="bk_pop" href="#kms.REF.pitteloud.2002a.152">Pitteloud et al [2002a]</a>, <a class="bk_pop" href="#kms.REF.massin.2003.2003">Massin et al [2003]</a>, <a class="bk_pop" href="#kms.REF.costabarbosa.2013.e943">Costa-Barbosa et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AXL</i>&#x000a0;<sup>2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD to normal puberty&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or normosmia&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.salianmehta.2014.1452">Salian-Mehta et al [2014]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CCDC141</i></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.hutchins.2016.1956">Hutchins et al [2016]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHD7</i>&#x000a0;<sup>1,&#x000a0;2</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD to normal puberty&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or normosmia&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>High-arched or cleft palate</div></li><li class="half_rhythm"><div>Dental agenesis</div></li><li class="half_rhythm"><div>Auricular dysplasia</div></li><li class="half_rhythm"><div>Perceptive deafness &#x00026; hypoplasia of semicircular canals</div></li><li class="half_rhythm"><div>Coloboma</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Intellectual disability</div></li></ul>
</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.kim.2008.511">Kim et al [2008]</a>, <a class="bk_pop" href="#kms.REF.jongmans.2009.65">Jongmans et al [2009]</a>, <a class="bk_pop" href="#kms.REF.costabarbosa.2013.e943">Costa-Barbosa et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DUSP6</i>&#x000a0;<sup>2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD to normal puberty&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or normosmia&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.miraoui.2013.725">Miraoui et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FEZF1</i>&#x000a0;<sup>1</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.kotan.2014.326">Kotan et al [2014]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGF8</i>&#x000a0;<sup>1,&#x000a0;2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD to normal puberty&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or normosmia&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cleft lip and/or palate</div></li><li class="half_rhythm"><div>Hearing loss</div></li><li class="half_rhythm"><div>Ocular hypertelorism</div></li><li class="half_rhythm"><div>Hyperlaxity of the digits</div></li><li class="half_rhythm"><div>Camptodactyly</div></li></ul>
</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.falardeau.2008.2822">Falardeau et al [2008]</a>, <a class="bk_pop" href="#kms.REF.trarbach.2010a.3491">Trarbach et al [2010a]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGF17</i>&#x000a0;<sup>2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD to normal puberty&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or normosmia&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.miraoui.2013.725">Miraoui et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR1</i>&#x000a0;<sup>1,&#x000a0;2</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complete IGD to normal puberty<br />IGD in males &#x0003e; females</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or normosmia&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Synkinesia (in ~10%)</div></li><li class="half_rhythm"><div>Cleft lip and/or palate</div></li><li class="half_rhythm"><div>Agenesis of 1+ teeth</div></li><li class="half_rhythm"><div>Digit malformations (brachydactyly, syndactyly)</div></li></ul>
</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.dod_.2003.463">Dod&#x000e9; et al [2003]</a>, <a class="bk_pop" href="#kms.REF.pitteloud.2006b.60">Pitteloud et al [2006b]</a>, <a class="bk_pop" href="#kms.REF.costabarbosa.2013.e943">Costa-Barbosa et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FLRT3</i>&#x000a0;<sup>2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD to normal puberty&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or normosmia&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.miraoui.2013.725">Miraoui et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GNRH1</i>&#x000a0;<sup>1,&#x000a0;2</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD (recessive); IGD to normal puberty&#x000a0;<sup>4</sup> (<a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants)</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normosmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.bouligand.2009.2742">Bouligand et al [2009]</a>, <a class="bk_pop" href="#kms.REF.chan.2009.11703">Chan et al [2009]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GNRHR</i>&#x000a0;<sup>1,&#x000a0;2</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD (recessive); IGD to normal puberty&#x000a0;<sup>4</sup> (<a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants)</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normosmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.de_roux.1997.1597">de Roux et al [1997]</a><br /><a class="bk_pop" href="#kms.REF.cerrato.2006.s3">Cerrato et al [2006]</a>, <a class="bk_pop" href="#kms.REF.b_d_carrats.2007.368">B&#x000e9;d&#x000e9;carrats &#x00026; Kaiser [2007]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HS6ST1</i>&#x000a0;<sup>2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD to normal puberty&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or normosmia&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.tornberg.2011.11524">Tornberg et al [2011]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IL17RD</i>&#x000a0;<sup>1,&#x000a0;2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD to normal puberty&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hearing loss</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.miraoui.2013.725">Miraoui et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KISS1</i>&#x000a0;<sup>1,&#x000a0;2</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD (recessive); IGD to normal puberty&#x000a0;<sup>4</sup> (<a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants)</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normosmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.topaloglu.2012.629">Topaloglu et al [2012]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KISS1R</i>&#x000a0;<sup>1,&#x000a0;2</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD (recessive); IGD to normal puberty&#x000a0;<sup>4</sup> (<a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants)</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normosmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.de_roux.2003.10972">de Roux et al [2003]</a>, <a class="bk_pop" href="#kms.REF.seminara.2003.1614">Seminara et al [2003]</a>, <a class="bk_pop" href="#kms.REF.semple.2005.1849">Semple et al [2005]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NSMF</i>&#x000a0;<sup>2</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD to normal puberty&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or normosmia&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.xu.2011.1613">Xu et al [2011]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POLR3B</i></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD (recessive)</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normosmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.richards.2017.19">Richards et al [2017]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PROKR2</i>&#x000a0;<sup>1,&#x000a0;2,&#x000a0;4</sup><br />and <i>PROK2</i>&#x000a0;<sup>1,&#x000a0;2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD (recessive); IGD to normal puberty&#x000a0;<sup>4</sup> (<a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants)</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or normosmia&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.costabarbosa.2013.e943">Costa-Barbosa et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SEMA3A</i>&#x000a0;<sup>2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD to normal puberty&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or hyposmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.cariboni.2011.336">Cariboni et al [2011]</a>, <a class="bk_pop" href="#kms.REF.hanchate.2012.e1002896">Hanchate et al [2012]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SEMA3E</i>&#x000a0;<sup>2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.cariboni.2015.2413">Cariboni et al [2015]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SOX10</i>&#x000a0;<sup>1</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hearing loss</div></li><li class="half_rhythm"><div>Iris hypopigmentation</div></li></ul>
</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.pingault.2013.707">Pingault et al [2013]</a>, <a class="bk_pop" href="#kms.REF.suzuki.2015.212">Suzuki et al [2015]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPRY4</i>&#x000a0;<sup>2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD to normal puberty&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or normosmia&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.miraoui.2013.725">Miraoui et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SRA1</i></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normosmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.kotan.2016.125">Kotan et al [2016]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TAC3</i>&#x000a0;<sup>1,&#x000a0;2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD (recessive); IGD to normal puberty&#x000a0;<sup>4</sup> (<a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants)</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normosmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.topaloglu.2009.354">Topaloglu et al [2009]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TACR3</i>&#x000a0;<sup>1,&#x000a0;2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD (recessive); IGD to normal puberty&#x000a0;<sup>4</sup> (<a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants)</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normosmia</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.guran.2009.3633">Guran et al [2009]</a>, <a class="bk_pop" href="#kms.REF.topaloglu.2009.354">Topaloglu et al [2009]</a>, <a class="bk_pop" href="#kms.REF.gianetti.2010.2857">Gianetti et al [2010]</a></td></tr><tr><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WDR11</i>&#x000a0;<sup>2,&#x000a0;4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IGD to normal puberty&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anosmia or normosmia&#x000a0;<sup>4</sup></td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_2 hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_kms.T.isolated_gnrh_deficiency_igd_pheno_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.kim.2010.465">Kim et al [2010]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="kms.TF.3.1"><p class="no_margin">Monogenic inheritance</p></div></dd><dt>2. </dt><dd><div id="kms.TF.3.2"><p class="no_margin">Oligogenic inheritance</p></div></dd><dt>3. </dt><dd><div id="kms.TF.3.3"><p class="no_margin">Often asymptomatic; also reported in KS of unknown cause</p></div></dd><dt>4. </dt><dd><div id="kms.TF.3.4"><p class="no_margin">Depending on <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, especially in the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state</p></div></dd></dl></div></div></div></div></div><div id="kms.Pathophysiology"><h3>Pathophysiology</h3><p>Pulsatile secretion of GnRH into the hypophyseal portal circulation represents the initial neuroendocrine step in the regulation of the hypothalamo-pituitary-gonadal (HPG) axis in both sexes. Thus, this specialized GnRH neuronal network plays a commanding role in this biologic hierarchy and controls episodic gonadotropin secretion, modulates gonadal steroid feedback, and ultimately determines the initiation or suppression of pubertal development and fertility across the life cycle [<a class="bk_pop" href="#kms.REF.hoffman.1982.1237">Hoffman &#x00026; Crowley 1982</a>, <a class="bk_pop" href="#kms.REF.crowley.1985.473">Crowley et al 1985</a>].</p><p>Under normal conditions, the GnRH neuronal network undergoes a series of dynamic changes from fetal life to adulthood. The initiation of GnRH secretion is initiated in early fetal life and remains active until the first several months of infancy (representing the "mini-puberty"), and then becomes remarkably dampened during the years of the childhood "quiescence" [<a class="bk_pop" href="#kms.REF.waldhauser.1981.71">Waldhauser et al 1981</a>]. At puberty, unknown biologic triggers re-ignite GnRH secretion, resulting in full sexual maturation. Therefore, the controls of the reproductive axis are in dynamic flux, turning on and turning off in response to as-yet-unknown biologic signals at various points in the reproductive life cycle.</p><p>In individuals with IGD, analyses of the pulsatile pattern of gonadotropins have demonstrated a rather broad spectrum of abnormal developmental patterns varying from completely absent GnRH-induced LH pulses to sleep-entrained GnRH release that is indistinguishable from that of early puberty [<a class="bk_pop" href="#kms.REF.spratt.1987.283">Spratt et al 1987</a>, <a class="bk_pop" href="#kms.REF.nachtigall.1997.410">Nachtigall et al 1997</a>, <a class="bk_pop" href="#kms.REF.raivio.2007.863">Raivio et al 2007</a>]. This broad spectrum of neuroendocrine activity accounts for the variable reproductive phenotypes observed in persons with IGD.</p></div><div id="kms.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Gene-specific phenotypes have been noted; see <a class="figpopup" href="/books/NBK1334/table/kms.T.isolated_gnrh_deficiency_igd_pheno/?report=objectonly" target="object" rid-figpopup="figkmsTisolatedgnrhdeficiencyigdpheno" rid-ob="figobkmsTisolatedgnrhdeficiencyigdpheno">Table 3</a> and <a class="figpopup" href="/books/NBK1334/figure/kms.F4/?report=objectonly" target="object" rid-figpopup="figkmsF4" rid-ob="figobkmsF4">Figure 4</a>.</p><p>No reproductive or non-reproductive <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is specific to a single <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or particular type of pathogenic variant in any of the IGD-related genes.</p></div><div id="kms.Penetrance"><h3>Penetrance</h3><p>The underlying genetic etiology typically determines the <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of both reproductive and non-reproductive phenotypes.</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> for the KS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (both IGD and anosmia) is generally complete in males with an <i>ANOS1</i> (<i>KAL1</i>) <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. However, other non-reproductive phenotypes may have variable penetrance even in the setting of the same <i>ANOS1</i> (<i>KAL1</i>) defect. One set of identical twin males with a small <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in <i>ANOS1</i> (<i>KAL1</i>) with discordant neuroendocrine and non-reproductive phenotypes has been documented: one twin had a ventricular septal defect and a much greater LH and FSH response to a serial LH-RH stimulation test, whereas the other had exotropia and a lower response to the serial LH-RH stimulation test [<a class="bk_pop" href="#kms.REF.matsuo.2000.783">Matsuo et al 2000</a>].</p><p>Penetrance for IGD is also fairly high when pathogenic variants occur in the <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> state (i.e., recessive variants) (<i>FEZF1</i>, <i>GNRH1</i>, <i>GNRHR</i>, <i>IL17RD, KISS1</i>, <i>KISS1R</i>, <i>TAC3</i>, <i>TACR3</i>). However, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> for the reproductive <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in those with pathogenic <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> variants in almost all known IGD-related genes is incomplete as individuals with normal gonadal function who are heterozygous for pathogenic variants in these genes have been documented. Discordance for KS has also been demonstrated in identical twins, suggesting that additional modifiers may play a role in phenotypic expression [<a class="bk_pop" href="#kms.REF.hipkin.1990.198">Hipkin et al 1990</a>].</p><p>Penetrance for anosmia in men with an <i>ANOS1</i> (<i>KAL1</i>) <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is generally complete, whereas <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> for abnormal olfactory function in individuals with IGD and <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in several genes (<i>CHD7</i>, <i>FGFR1</i>, <i>FGF8</i>, <i>FGF17</i>, <i>HS6ST1</i>, <i>NSMF</i>, <i>PROK2</i>, <i>PROKR2</i>) is incomplete as normosmia, hyposmia, or anosmia can be seen [<a class="bk_pop" href="#kms.REF.pitteloud.2006a.6281">Pitteloud et al 2006a</a>, <a class="bk_pop" href="#kms.REF.cole.2008.3551">Cole et al 2008</a>, <a class="bk_pop" href="#kms.REF.falardeau.2008.2822">Falardeau et al 2008</a>, <a class="bk_pop" href="#kms.REF.miraoui.2013.725">Miraoui et al 2013</a>, <a class="bk_pop" href="#kms.REF.balasubramanian.2014.17953">Balasubramanian et al 2014</a>].</p></div><div id="kms.Nomenclature"><h3>Nomenclature</h3><p>The biochemical term "hypogonadotropic hypogonadism" has evolved with the increased understanding of reproductive physiology.</p><p>The term &#x0201c;hypogonadism&#x0201d; refers to impaired sexual development based on findings from the individual&#x02019;s clinical history (e.g., amenorrhea, hot flashes, erectile dysfunction) as well as physical examination (e.g., small testes, vaginal pallor).</p><p>With greater understanding of the hypothalamo-pituitary-gonadal (HPG) axis (see <a href="#kms.Pathophysiology">Pathophysiology</a>) and the introduction of urinary gonadotropin measurements, the term "<b>hyper</b>gonadotropic" hypogonadism was used to identify those with a primary gonadal defect, while "<b>hypo</b>gonadotropic" hypogonadism identified those with a central (i.e., pituitary or hypothalamic) defect.</p><p>When anatomic (and later functional) causes of central hypogonadism were identified, "<a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a>" or "<a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a>" hypogonadotropic hypogonadism (IHH) came into use to indicate those individuals in whom secondary causes of hypogonadotropic hypogonadism had been excluded.</p><p>Subsequently the ability to measure the effect of exogenous GnRH administration demonstrated that the vast majority of individuals with "<a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a>" HH had a functional deficiency of GnRH resulting from a defect in GnRH biosynthesis, secretion, and/or action (hence "<a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> GnRH deficiency" [IGD]). Aside from hypothalamic GnRH deficiency, individuals with IGD typically have normal pituitary function tests and their hypogonadism typically responds to a physiologic regimen of exogenous GnRH [<a class="bk_pop" href="#kms.REF.hoffman.1982.1237">Hoffman &#x00026; Crowley 1982</a>].</p><p>At this point, the term "<a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> GnRH deficiency" (IGD) more properly reflects the current understanding of the clinical entity rather than the previous biochemical description of IHH and, thus, is the better term for what was previously called IHH.</p></div><div id="kms.Prevalence"><h3>Prevalence</h3><p>A recent epidemiologic study in Finland showed a minimal incidence of KS of 1:30,000 in males and 1:125,000 in females [<a class="bk_pop" href="#kms.REF.laitinen.2011.41">Laitinen et al 2011</a>].</p><p>In the authors&#x02019; cohort of 250 individuals with IGD, males predominate with a male-to-female ratio of nearly 4:1 [<a class="bk_pop" href="#kms.REF.seminara.1998.521">Seminara et al 1998</a>].</p><p>KS accounts for nearly two thirds of individuals with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> GnRH deficiency (IGD).</p></div></div><div id="kms.Genetically_Related_Allelic_Disorder"><h2 id="_kms_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p><b><i>CHD7</i>.</b> Heterozygous pathogenic variants or microdeletions in <i>CHD7</i> can also cause <a href="/books/n/gene/charge/">CHARGE syndrome</a>. The syndrome is characterized by (and derives its name from) <i>c</i>oloboma, <i>h</i>eart abnormalities, choanal <i>a</i>tresia, <i>r</i>etardation of growth and development, <i>g</i>enital hypoplasia, and <i>e</i>ar abnormalities [<a class="bk_pop" href="#kms.REF.vissers.2004.955">Vissers et al 2004</a>]. The genital abnormalities in CHARGE syndrome are caused by hypogonadotropic hypogonadism and are frequently accompanied by olfactory defects and cleft lip/palate [<a class="bk_pop" href="#kms.REF.pinto.2005.5621">Pinto et al 2005</a>].</p><p><b><i>FGFR1</i>.</b> In addition to KS with highly <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a>, other phenotypes associated with pathogenic variants in <i>FGFR1</i> include Pfeiffer syndrome type 1 and osteoglophonic dwarfism.</p><ul><li class="half_rhythm"><div>Of the pathogenic variants that cause Pfeiffer syndrome, 95% occur in <i>FGFR2</i> and only 5% occur in <i>FGFR1</i> (see <a href="/books/n/gene/craniosynostosis/"><i>FGFR</i>-Related Craniosynostosis Syndromes</a>). Pfeiffer syndrome type 1 is characterized by coronal craniosynostosis with moderate-to-severe midface hypoplasia, usually normal intellect, broad and medially deviated thumbs, and great toes with variable degree of brachydactyly. Hearing loss and hydrocephalus can be seen on occasion.</div></li><li class="half_rhythm"><div>Osteoglophonic dwarfism involves rhizomelic dysplasia, <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, fibrous dysplasia, and clover-leaf skull.</div></li></ul><p><b><i>SOX10</i>.</b> Heterozygous pathogenic variants or microdeletions in <i>SOX10</i> can also cause Waardenburg syndrome, without IGD. The syndrome is characterized by deafness, skin/hair/iris hypopigmentation, Hirschsprung disease, and neurologic defects [<a class="bk_pop" href="#kms.REF.pingault.2013.707">Pingault et al 2013</a>].</p></div><div id="kms.Differential_Diagnosis"><h2 id="_kms_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Other Causes of Hypogonadotropic Hypogonadism</b></p><p>Hypogonadotropic hypogonadism refers to a diverse group of clinical conditions with characteristic biochemical findings of inappropriately low serum concentrations of LH (luteinizing hormone) and FSH (follicle stimulating hormone) occurring in the setting of hypogonadism.</p><p>Distinguishing between <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> GnRH deficiency (IGD) and secondary causes of hypogonadotropic hypogonadism and <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a>/genetic causes of hypogonadotropic hypogonadism often requires additional clinical, laboratory, and radiologic evaluations. These may include physical examination for other systemic findings, family history, and measurement of serum concentration of other pituitary hormones, serum iron studies, and hypothalamic/pituitary imaging. Of note, despite a thorough evaluation, IGD can sometimes be difficult to distinguish from other causes of decreased gonadotropin secretion. Hence, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the known IGD-related genes (<a class="figpopup" href="/books/NBK1334/table/kms.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figkmsTmoleculargenetictestingusedin" rid-ob="figobkmsTmoleculargenetictestingusedin">Table 2</a>) may help make the diagnosis of IGD</p><p><b>Acquired causes.</b> Multiple disease processes ranging from systemic diseases to brain and pituitary tumors can result in impaired gonadotropin secretion. These conditions, which can be relatively common and frequently give rise to defects in other pituitary hormones, include the following:</p><ul><li class="half_rhythm"><div>CNS or pituitary tumors</div></li><li class="half_rhythm"><div>Pituitary apoplexy</div></li><li class="half_rhythm"><div>Brain/pituitary radiation</div></li><li class="half_rhythm"><div>Head trauma</div></li><li class="half_rhythm"><div>Drugs: GnRH agonists/antagonists, glucocorticoids, narcotics, chemotherapy, drugs causing hyperprolactinemia</div></li><li class="half_rhythm"><div>Functional deficiency resulting from hyperprolactinemia, chronic systemic illness, eating disorders, malnutrition, hypothyroidism, diabetes mellitus, Cushing&#x02019;s disease</div></li><li class="half_rhythm"><div>Systemic diseases such as sarcoidosis and histiocytosis</div></li></ul><p><b>Syndromes</b> listed in <a class="figpopup" href="/books/NBK1334/table/kms.T.syndromes_associated_with_hypogona/?report=objectonly" target="object" rid-figpopup="figkmsTsyndromesassociatedwithhypogona" rid-ob="figobkmsTsyndromesassociatedwithhypogona">Table 4</a> can be associated with hypogonadotropic hypogonadism along with other significant clinical findings and/or other pituitary hormone deficits. .</p><div id="kms.T.syndromes_associated_with_hypogona" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Syndromes Associated with Hypogonadotropic Hypogonadism</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1334/table/kms.T.syndromes_associated_with_hypogona/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kms.T.syndromes_associated_with_hypogona_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Syndrome</th><th id="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Genetic Mechanism / Associated Gene</th><th id="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th></tr></thead><tbody><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bbs/">Bardet-Biedl syndrome</a></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic variants in of one of 19 genes&#x000a0;<sup>1</sup></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental delay, visual impairment, postaxial polydactyly, obesity, renal impairment</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/charge/">CHARGE syndrome</a></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHD7</i></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Coloboma, heart defect, choanal atresia, growth retardation, ear abnormalities</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.pinto.2005.5621">Pinto et al [2005]</a>, <a class="bk_pop" href="#kms.REF.lalani.2009">Lalani &#x00026; Belmont [2009]</a></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Combined pituitary hormone deficiency</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HESX1</i></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;">Various degrees of hypopituitarism</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_4" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/prop1/#prop1.Differential_Diagnosis"><i>PROP1</i>-Related Combined Pituitary Hormone Deficiency</a>, <b>Combined Pituitary Hormone Deficiencies</b></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><i>LHX3</i></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><i>LHX4</i></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><i>POU1F1</i></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/prop1/"><i>PROP1</i></a></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gordon-Holmes syndrome</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>OTUD4</i><br /><a href="/books/n/gene/pnpla6-dis/"><i>PNPLA6</i></a><br /><i>RNF216</i><br /><i>STUB1</i></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebellar ataxia, dementia</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.seminara.2002.1607">Seminara et al [2002]</a>, <a class="bk_pop" href="#kms.REF.margolin.2013.1992">Margolin et al [2013]</a></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hemochromatosis/"><i>HFE</i>-associated hereditary hemochromatosis</a></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HFE</i></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cirrhosis, diabetes, cardiomyopathy, arthritis, skin hyperpigmentation</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Obesity syndromes</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PCSK1</i> (<i>PC1</i>)</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Morbid obesity, hypocortisolism, hypoinsulinemia</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.jackson.1997.303">Jackson et al [1997]</a>, <a class="bk_pop" href="#kms.REF.jackson.2003.1550">Jackson et al [2003]</a></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>LEP</i></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Morbid obesity</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.strobel.1998.213">Strobel et al [1998]</a></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>LEPR</i></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.cl_ment.1998.398">Cl&#x000e9;ment et al [1998]</a></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pws/">Prader-Willi syndrome</a></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Loss of paternal 15q11.2</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypotonia in infancy, developmental delay, cryptorchidism/microphallus in males, abnormal satiety, intellectual disability</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.cassidy.2012.10">Cassidy et al [2012]</a></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUBB3</i> E410K syndrome (see <a href="/books/n/gene/tubulin-ov/">Tubulinopathies Overview</a>)</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUBB3</i></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cfeom/">Congenital fibrosis of the extraocular muscles</a>, facial weakness, developmental delay, sensorimotor polyneuropathy, stereotyped midface hypoplasia, intellectual disabilities &#x00026; vocal cord paralysis, tracheomalacia &#x00026; cyclic vomiting</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.chew.2013.522">Chew et al [2013]</a>, <a class="bk_pop" href="#kms.REF.balasubramanian.2015.e473">Balasubramanian et al [2015]</a></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ahc/">X-linked adrenal hypoplasia congenita</a></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NR0B1</i></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Adrenal failure</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Xp22.3 <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion-syndrome/">contiguous gene deletion syndrome</a></td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Xp22.3 microdeletion</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">KS, icthyosis, short stature, intellectual disability, chondrodysplasia punctata, digital synkinesia</td><td headers="hd_h_kms.T.syndromes_associated_with_hypogona_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kms.REF.bick.1989.100">Bick et al [1989]</a>, <a class="bk_pop" href="#kms.REF.hou.2005.643">Hou [2005]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="kms.TF.4.1"><p class="no_margin">At least 19 genes are associated with BBS: <i>ARL6</i>, <i>BBIP1</i>, <i>BBS1</i>, <i>BBS2</i>, <i>BBS4</i>, <i>BBS5</i>, <i>BBS7</i>, <i>BBS9</i>, <i>BBS10</i>, <i>BBS12</i>, <i>CEP290</i>, <i>IFT27</i>, <i>LZTFL1</i>, <i>MKKS</i>, <i>MKS1</i>, <i>SDCCAG8</i>, <i>TRIM32</i>, <i>TTC8</i>, and <i>WDPCP</i>.</p></div></dd></dl></div></div></div><div id="kms.Differential_Diagnosis_of_IGD_at_Spe"><h3>Differential Diagnosis of IGD at Specific Developmental Stages</h3><p><b>Infancy.</b> Although males with IGD may have cryptorchidism and/or microphallus at birth, these features are not specific for IGD. Numerous disorders can give rise to these genital defects, ranging from <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> findings to syndromes such as <a href="/books/n/gene/pws/">Prader-Willi syndrome</a> or abnormal pituitary development (see <a href="/books/n/gene/prop1/"><i>PROP1</i>-Related Combined Pituitary Hormone Deficiency</a>). This is particularly true for cryptorchidism, the most common birth defect of the male genitalia.</p><p><b>Adolescence<i>.</i></b> Perhaps the most difficult distinction to make is between IGD and constitutional delay of puberty (CDP). Time is a critical factor in distinguishing between these two conditions. In CDP, spontaneous and otherwise normal puberty eventually occurs, whereas in IGD spontaneous sexual maturation does not occur at any time. Evidence suggests that CDP and IGD are not discrete clinical entities but rather are part of a phenotypic spectrum. In families with IGD, delayed puberty occurs at a much higher frequency in otherwise "normal" family members than in the general population, suggesting that CDP may represent a milder clinical variant of the IGD <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#kms.REF.waldstreicher.1996.4388">Waldstreicher et al 1996</a>, <a class="bk_pop" href="#kms.REF.pitteloud.2006a.6281">Pitteloud et al 2006a</a>].</p><p>Although the distinction between CDP and IGD cannot be reliably made at any age, age 18 years has traditionally been suggested as the age at which IGD can be diagnosed; however, the recent description of IGD "reversal" occurring in persons in their 20s and later raises the possibility that such individuals may have a severe form of CDP [<a class="bk_pop" href="#kms.REF.raivio.2007.863">Raivio et al 2007</a>]. In contrast, the presence of other clinical features associated with IGD (e.g., anosmia, synkinesia) (<a class="figpopup" href="/books/NBK1334/table/kms.T.isolated_gnrh_deficiency_igd_pheno/?report=objectonly" target="object" rid-figpopup="figkmsTisolatedgnrhdeficiencyigdpheno" rid-ob="figobkmsTisolatedgnrhdeficiencyigdpheno">Table 3</a>) may result in a diagnosis of IGD being made before age 18 years.</p><p>Currently, no clinically available test can reliably differentiate CDP from IGD. Data analyses have suggested that the mean serum concentrations of LH and sex hormones after GnRH or hCG (human chorionic gonadotropin) stimulation vary significantly between individuals with CDP and those with IGD. However, the clinical utility of measuring serum LH and sex hormone concentrations after stimulation with GnRH and hCG is limited by the significant variation in individual LH and sex hormone serum concentrations, resulting in considerable overlap between groups [<a class="bk_pop" href="#kms.REF.degros.2003.23">Degros et al 2003</a>].</p><p>A peak-to-basal ratio of free alpha subunit (FAS) after the administration of GnRH has been proposed to help distinguish between CDP and IGD with a <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> and specificity in the 95% range and an overlap rate of 10% [<a class="bk_pop" href="#kms.REF.mainieri.2003.307">Mainieri &#x00026; Elnecave 2003</a>]. More recently, combining a 19-day hCG test with a conventional GnRH test has also been proposed to improve the differentiation between IGD and CDP [<a class="bk_pop" href="#kms.REF.segal.2009.780">Segal et al 2009</a>]. However, given the relatively small number of individuals studied and limited follow-up in both studies, prospective validation is required to determine the true diagnostic reliability of the above tests.</p><p><a class="figpopup" href="/books/NBK1334/figure/kms.F1/?report=objectonly" target="object" rid-figpopup="figkmsF1" rid-ob="figobkmsF1">Figure 1</a> and <a class="figpopup" href="/books/NBK1334/figure/kms.F2/?report=objectonly" target="object" rid-figpopup="figkmsF2" rid-ob="figobkmsF2">Figure 2</a> provide testing algorithms for establishing the diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> GnRH deficiency in males and females, respectively.</p></div></div><div id="kms.Management"><h2 id="_kms_Management_">Management</h2><div id="kms.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with IGD, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div class="half_rhythm">Assessment of clinical manifestations of hypogonadism based on the age and sex of the individual, if not already performed as part of the diagnostic work up (see <a href="#kms.Diagnosis">Diagnosis</a> and <a class="figpopup" href="/books/NBK1334/table/kms.T.tanner_staging/?report=objectonly" target="object" rid-figpopup="figkmsTtannerstaging" rid-ob="figobkmsTtannerstaging">Table 1</a>)</div></li><li class="half_rhythm"><div class="half_rhythm">Assessment of laboratory findings* of hypogonadotropic hypogonadism if not already performed as part of the diagnostic work up</div><div class="half_rhythm">* Serum concentration of LH (luteinizing hormone) and FSH (follicle-stimulating hormone) and in males total testosterone (T) &#x0003c;100 ng/dL and in females estradiol (E<sub>2</sub>) &#x0003c;50 pg/mL</div></li><li class="half_rhythm"><div class="half_rhythm">Assessment for presence of possible non-reproductive features including: renal ultrasound examination (to detect unilateral renal agenesis), hearing tests (to detect sensorineural hearing loss), skeletal survey (to detect limb/spine bony abnormalities), dental exam (to detect dental agenesis), eye exam (to detect iris and/or chorioretinal coloboma) and developmental assessment (if there is evidence of developmental delay)</div></li><li class="half_rhythm"><div class="half_rhythm">In addition to assessing the degree of hypogonadism/GnRH deficiency, potential deterioration in bone health that may have resulted from periods of low-circulating sex hormones needs to be addressed. Depending on the timing of puberty, duration of GnRH deficiency, and other osteoporotic risk factors (e.g., glucocorticoid excess, smoking), one should consider obtaining a bone mineral density study (see <a href="#kms.Prevention_of_Secondary_Complication">Prevention of Secondary Complications</a>).</div></li><li class="half_rhythm"><div class="half_rhythm">Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="kms.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>An expert European consensus statement on the management of IGD has recently been published [<a class="bk_pop" href="#kms.REF.boehm.2015">Boehm et al 2015</a>] (<a href="http://www.nature.com/nrendo/journal/v11/n9/full/nrendo.2015.112.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>).</p><p>Typically, a definitive diagnosis of IGD is made around age 18 years. Occasionally, however, a high clinical suspicion of IGD may be present in an adolescent presenting with anosmia and delayed puberty or in an infant with microphallus and cryptorchidism.</p><div id="kms.Males_with_IGD_Age__18_Years"><h4>Males with IGD Age &#x02265;18 Years</h4><p>Treatment options include sex steroids, gonadotropins, and pulsatile GnRH administration. Choice of therapy in adults is determined by the goal(s) of treatment (i.e., to induce and maintain secondary sex characteristics and/or to induce and maintain fertility). The selection of hormone replacement therapy is also based on the preference of the individual being treated; however, when fertility is not immediately desired, replacement with testosterone therapy is the most practical option. As the majority of individuals with IGD have not progressed through puberty at the time of diagnosis, initial therapy should be started at low doses and gradually increased to adult doses once the development of secondary sexual characteristics is achieved.</p><p><b>Hormone replacement therapy for males not desiring fertility</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Testosterone therapy</b> in the form of injectable and transdermal routes of testosterone administration is typically used to both induce puberty and maintain adult levels of testosterone. Recently nasal testosterone has become available but use has not been reported in patients with IGD.</div><div class="half_rhythm">The injectable testosterone preparations have a "roller-coaster" pharmacokinetic effect, with peak and trough levels that can go to extraphysiologic levels; thus, the transdermal preparations have the added benefit of offering a more favorable pharmacokinetic profile. A typical adult dose of testosterone replacement is 200 mg of testosterone ester injection every two weeks or 5 g of a 1% testosterone gel every day. Doses do vary with newer testosterone preparations; manufacturer&#x02019;s instructions should be followed for individual testosterone preparations.</div><div class="half_rhythm">Men using topical androgen replacement must take care to avoid exposing other individuals to treated skin. Anecdotal reports suggest that the transmission of clinically effective levels of testosterone from the patient to other family members (including women and children) is possible with undesirable side effects.</div><div class="half_rhythm">Once puberty is initiated, testosterone replacement therapy is usually required indefinitely to ensure normal sexual function and maintenance of proper muscle, bone, and red blood cell mass.</div><div class="half_rhythm">However, in approximately 10% of males, reversal of IGD may occur; thus, if clinical evidence shows endogenous activity of the hypothalamo-pituitary-axis (e.g., testicular growth on testosterone, maintained testosterone levels despite missing/withholding therapy), a brief washout of testosterone therapy should be done with monitoring of testosterone levels. If testosterone levels fall, therapy should be reinitiated. If levels are normal, no further testosterone therapy will be required; serial monitoring of levels should be undertaken, as some individuals may require reinitiation of therapy.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Human chorionic gonadotropin (hCG).</b> An alternative to testosterone therapy, hCG injections promote testicular growth, normalize serum concentration of testosterone, and induce development of secondary sexual characteristics.</div><div class="half_rhythm">In adults, treatment with hCG is usually initiated at 1,500 IU intramuscularly or subcutaneously every other day to normalize serum testosterone concentrations. Dose should be increased by increments of 250 IU if serum testosterone levels remain low.</div><div class="half_rhythm">Treatment with hCG must be weighed against the increased risk of developing gynecomastia (resulting from the estrogen produced by stimulation of the testes with hCG). To some extent the risk of gynecomastia can be minimized by gradually reducing the dose of hCG to the minimum required to sustain a serum testosterone concentration in the mid-normal range (~500 ng/dL).</div></li></ul></div><div id="kms.Male_InfantsAdolescents_with_Suspici"><h4>Male Infants/Adolescents with Suspicion of IGD</h4><p>If IGD is clinically suspected (e.g., low testosterone levels with low/normal gonadotropins) low-dose testosterone or hCG therapy can be given in early infancy to boys with microphallus to increase penile length [<a class="bk_pop" href="#kms.REF.binabbas.1999.579">Bin-Abbas et al 1999</a>, <a class="bk_pop" href="#kms.REF.young.2012.707">Young 2012</a>].</p><p>Since a definitive diagnosis of IGD may not be possible until age 18 years, after infancy these boys do not generally need to be treated until around the time of puberty. At this time, if a high suspicion of IGD remains (e.g., associated anosmia and delay in onset puberty), these subjects may benefit from early initiation of hormonal replacement therapy with either testosterone or hCG treatment early in the pubertal period. A suggestive puberty induction regimen in adolescents is to start a long-acting testosterone ester at a dose of 25-50 mg, given intramuscularly every two weeks. The doses can be gradually increased by 25-50 mg every two to three months until full virilization is achieved. Once adult doses (~200 mg/2 weeks) are reached, further adjustments are based on serum testosterone levels.</p><p><b>Hormone replacement therapy for males desiring fertility (fertility induction in males).</b> As testosterone replacement therapy suppresses spermatogenesis in the testes, gonadotropins or pulsatile GnRH therapy is usually required to realize the fertility potential in males.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Gonadotropin therapy.</b> In most males with IGD, a combination of gonadotropins (hCG along with either human menopausal gonadotropins [hMG] or recombinant FSH) is used to stimulate spermatogenesis. In males with very low testicular volumes (&#x02264;~8 mL) the initiating dose of hCG is usually 1,500 IU intramuscularly or subcutaneously every other day; FSH is added at doses ranging from 37.5 to 75 IU as either hMG or recombinant formulation. Trough serum testosterone concentrations (target: mid-normal range [~500 ng/dL]), trough serum FSH levels (target: mid-normal reference range), and sperm count are monitored to assess response. Recent trials show that in those with lower testicular volumes, priming with FSH prior to combination therapy may improve spermatogenic outcomes [<a class="bk_pop" href="#kms.REF.dwyer.2013.e1790">Dwyer et al 2013</a>].</div><div class="half_rhythm">In males with higher baseline testicular volumes, treatment with hCG alone may be sufficient to achieve spermatogenesis and conception [<a class="bk_pop" href="#kms.REF.burris.1988.1144">Burris et al 1988</a>]. However, if after six to nine months, semen analysis reveals persistent azoospermia or marked oligospermia, FSH is added to the regimen at doses ranging from 37.5 to 75 IU as either hMG or a recombinant formulation.</div><div class="half_rhythm">In either treatment, testicular volume must be tracked, as this is one of the primary determinants of successful spermatogenesis. In fact, sperm are rarely seen in the semen analysis until testicular volume reaches 8 mL [<a class="bk_pop" href="#kms.REF.whitcomb.1990.3">Whitcomb &#x00026; Crowley 1990</a>]. In most males without a history of cryptorchidism, sperm function is usually normal and conception can occur even with relatively low sperm counts. Note: <a class="bk_pop" href="#kms.REF.liu.2009.801">Liu et al [2009]</a> have noted that previous treatment with gonadotropins may reduce the period of subsequent gonadotropin treatment required for initiation of spermatogenesis.</div><div class="half_rhythm">If a pituitary defect exists, gonadotropin therapy becomes the treatment of choice.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Pulsatile GnRH stimulation vs. gonadotropin therapy.</b> While either gonadotropin therapy or pulsatile GnRH stimulation can induce spermatogenesis in approximately 90%-95% of men with IGD, some men have a better response to pulsatile GnRH stimulation than to gonadotropin therapy.</div><div class="half_rhythm">Subcutaneous administration of GnRH in a pulsatile manner through a portable pump that delivers a GnRH bolus every two hours is an efficient way of inducing testicular growth and spermatogenesis [<a class="bk_pop" href="#kms.REF.pitteloud.2002b.4128">Pitteloud et al 2002b</a>]. As the primary defect of IGD is typically localized to the hypothalamus, the pituitary responds appropriately to physiologic doses of GnRH. Note: In the US, pulsatile GnRH therapy is not currently approved by the Food and Drug Administration for the treatment of infertility in men and, thus, is available for such treatment only at specialized research centers.</div></li></ul></div><div id="kms.Females_with_IGD"><h4>Females with IGD</h4><p><b>Hormone replacement therapy for females not desiring fertility.</b> Although a definitive diagnosis of IGD in females is usually made around age 18 years, occasionally a high clinical suspicion of IGD may be present in an adolescent presenting with anosmia and delayed puberty, and therapy may need to be initiated earlier (age ~14 years)</p><ul><li class="half_rhythm"><div>To allow optimal breast development, initial treatment should consist of unopposed estrogen replacement via oral or topical preparations. Many formulations of estrogens are available; a suggested oral regimen is using premarin 0.3 mg daily to be increased gradually to an adult replacement dose of 1-1.25 mg daily.</div></li><li class="half_rhythm"><div>Once breast development is optimal, a progestin should be added for endometrial protection (e.g., cyclical Prometrium<sup>&#x000ae;</sup> 200 mg daily for 10-12 days).</div></li><li class="half_rhythm"><div>Although preference of the individual plays an important role in choice of treatment plan, low-estrogen formulations should be considered in women with clotting abnormalities (see <a href="/books/n/gene/factor-v-leiden/">Factor V Leiden Thrombophilia</a> and <a href="/books/n/gene/ptt/">Prothrombin Thrombophilia</a>).</div></li></ul><p><b>Hormone replacement therapy for females desiring fertility (fertility induction in females).</b> Pulsatile GnRH stimulation and exogenous gonadotropins are FDA approved for folliculogenesis in women with IGD. Either therapy should be administered with close supervision by physicians specializing in ovulation induction. Intravenous administration of GnRH at various frequencies throughout the menstrual cycle closely mimics the dynamics of normal menstrual cycles resulting in ovulation of a single follicle [<a class="bk_pop" href="#kms.REF.santoro.1986.11">Santoro et al 1986</a>]. This therapy offers a clear advantage over the traditional treatment with exogenous gonadotropins, which results in higher rates of both multiple gestation and ovarian hyperstimulation syndrome. For either approach, however, the rate of conception is approximately 30% per ovulatory cycle [<a class="bk_pop" href="#kms.REF.martin.1990">Martin et al 1990</a>].</p></div><div id="kms.Fertility_Options_in_Patients_with_I"><h4>Fertility Options in Patients with IGD if Fertility Induction is Unsuccessful</h4><p><b>In vitro fertilization.</b> Although successful spermatogenesis can be obtained in most males with IGD through pulsatile GnRH therapy or combined gonadotropin therapy, some men with KS caused by an <i>ANOS1</i> (<i>KAL1</i>) <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may have an atypical response to therapy [<a class="bk_pop" href="#kms.REF.sykiotis.2010a.3019">Sykiotis et al 2010a</a>]. In those who respond to therapy, low sperm numbers can often result in conception; however, if infertility continues despite successful spermatogenesis or if spermatogenesis fails to occur, in vitro fertilization (IVF) is an option.</p><p>Similarly, if spontaneous conception fails to occur in women with IGD who have undergone ovulation induction, IVF may be an option.</p></div></div><div id="kms.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Optimal calcium and vitamin D intake should be encouraged and specific treatment for decreased bone mass with bisphosphonates should be considered depending on the degree of bone mineralization (see <a href="#kms.Evaluations_Following_Initial_Diagno">Evaluations Following Initial Diagnosis</a>).</p></div><div id="kms.Surveillance"><h3>Surveillance</h3><p><b>Children of both sexes with findings suggestive of IGD</b> (e.g., microphallus, anosmia) should be monitored at regular intervals from age 11 years onwards with the following:</p><ul><li class="half_rhythm"><div>Assessment of sexual maturation by Tanner staging (<a class="figpopup" href="/books/NBK1334/table/kms.T.tanner_staging/?report=objectonly" target="object" rid-figpopup="figkmsTtannerstaging" rid-ob="figobkmsTtannerstaging">Table 1</a>)</div></li><li class="half_rhythm"><div>Measurement of serum concentrations of LH, FSH, and total testosterone (T) in males and estradiol (E<sub>2</sub>) in females</div></li><li class="half_rhythm"><div>Bone age determinations</div></li></ul><p><b>In individuals with a confirmed diagnosis of IGD</b>, serum sex steroid levels (to guide optimal hormone replacement) and bone mineral density should be monitored at regular intervals.</p></div><div id="kms.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from surveillance and prompt initiation of treatment.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family are known. However, a prepubertal child with a known pathogenic variant may progress through puberty in a normal fashion, delayed fashion, or not at all. Therefore, reevaluation of such individuals over time is important, and hormone treatment should be initiated only when IGD with impaired pubertal development is diagnosed.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family are not known, clinical review of at-risk relatives of pubertal age to assess clinical onset of signs of puberty and if delayed, to initiate appropriate therapy for pubertal induction.</div></li></ul><p>See <a href="#kms.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="kms.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="kms.Genetic_Counseling"><h2 id="_kms_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="kms.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) can be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner (see <a class="figpopup" href="/books/NBK1334/figure/kms.F3/?report=objectonly" target="object" rid-figpopup="figkmsF3" rid-ob="figobkmsF3">Figure 3</a>).</p><p>Almost all IGD-related genes have also been associated with indeterminate or <a class="def" href="/books/n/gene/glossary/def-item/oligogenic/">oligogenic</a> inheritance (especially when an IGD-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> occurs in the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state [<a class="bk_pop" href="#kms.REF.sykiotis.2010b.15140">Sykiotis et al 2010b</a>, <a class="bk_pop" href="#kms.REF.hanchate.2012.e1002896">Hanchate et al 2012</a>, <a class="bk_pop" href="#kms.REF.miraoui.2013.725">Miraoui et al 2013</a>]).</p><p>A three-generation family history should be obtained to understand the <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> of IGD to aid genetic testing and <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>. Detailed histories including questions regarding <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a>, reproductive features (e.g., microphallus and cryptorchidism, pubertal development, fertility/infertility), olfactory function (normal sense of smell, hyposmia, anosmia), and non-reproductive features (e.g., craniofacial abnormalities including cleft lip/palate/missing teeth, hearing loss, synkinesia of the digits, and renal agenesis) should be obtained for all family members. If other individuals with IGD or these associated findings are identified in the family, the mode of inheritance may become apparent. In the majority of individuals, however, no such family history is present.</p></div><div id="kms.Risk_to_Family_Members__XLinked_Inhe"><h3>Risk to Family Members &#x02013; X-Linked Inheritance</h3><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disease nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <i>ANOS1</i> (<i>KAL1</i>) <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>). Note: If a woman has more than one affected son and no other affected relatives and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> (maternal germline mosaicism has not been reported to date for <i>ANOS1</i>).</div></li><li class="half_rhythm"><div>If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>ANOS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, in which case the mother is not a carrier. About 70% of affected males represent simplex cases.</div></li></ul><p><b>Sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <i>ANOS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Male sibs who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; female sibs who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and may display some clinical features.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>With treatment, males with IGD can be fertile.</div></li><li class="half_rhythm"><div>Affected males transmit the <i>ANOS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to:</div><ul><li class="half_rhythm"><div>All of their daughters, who will be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and may display some clinical features.</div></li><li class="half_rhythm"><div>None of their sons.</div></li></ul></li></ul><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal uncles may be at risk of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and the maternal aunts may be at risk of being carriers for the <i>ANOS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The aunts' offspring, depending on their gender, may be at risk of being carriers or of being affected.</p><p><b>Heterozygote (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) detection.</b> Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the <i>ANOS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p>Notes: (1) Females <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>ANOS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may occasionally display clinical features that are diagnostic of IGD [<a class="bk_pop" href="#kms.REF.shaw.2011.e566">Shaw et al 2011</a>]. (2) Identification of female heterozygotes requires either (a) prior identification of the <i>ANOS1</i> pathogenic variant in the family or, (b) if an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male is not available for testing, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> first by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, and if no pathogenic variant is identified, by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div><div id="kms.Risk_to_Family_Members__Autosomal_Do"><h3>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> IGD have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> IGD may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by a <i>de novo</i> pathogenic variant is unknown.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include:</div><ul><li class="half_rhythm"><div>A detailed pubertal history of both parents; and</div></li><li class="half_rhythm"><div>Molecular genetic testing of both parents for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (germline mosaicism for an IGD-related pathogenic variant has been reported in one family [<a class="bk_pop" href="#kms.REF.sato.2006.220">Sato &#x00026; Ogata 2006</a>]).</div></li><li class="half_rhythm"><div>Evaluation of parents may determine that a parent has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> but has escaped previous diagnosis because of a milder phenotypic presentation, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, or late onset of the disorder. Therefore, an apparently negative family history cannot be fully confirmed until appropriate evaluations have been performed.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the pathogenic variant is 50% although their actual risk may be lower due to <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#kms.REF.sato.2006.220">Sato &#x00026; Ogata 2006</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> IGD has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; however, the actual risk may be less than 50% because of <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p><p><b>Other family member.</b> The risk to other family members depends on the genetic status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a known <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="kms.Risk_to_Family_Members__Autosomal_Re"><h3>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of a child with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> IGD are obligate heterozygotes (i.e., carriers of one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes are typically unaffected.</div></li><li class="half_rhythm"><div>Occasionally, heterozygotes display clinical features diagnostic of IGD [<a class="bk_pop" href="#kms.REF.cole.2008.3551">Cole et al 2008</a>, <a class="bk_pop" href="#kms.REF.gianetti.2010.2857">Gianetti et al 2010</a>, <a class="bk_pop" href="#kms.REF.sykiotis.2010b.15140">Sykiotis et al 2010b</a>, <a class="bk_pop" href="#kms.REF.chan.2011.e1771">Chan et al 2011</a>, <a class="bk_pop" href="#kms.REF.miraoui.2013.725">Miraoui et al 2013</a>]; this may be due to unknown environmental, epigenetic, or <a class="def" href="/books/n/gene/glossary/def-item/oligogenic/">oligogenic</a> factors.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> IGD has a 25% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Occasionally, heterozygotes display clinical features diagnostic of IGD [<a class="bk_pop" href="#kms.REF.cole.2008.3551">Cole et al 2008</a>, <a class="bk_pop" href="#kms.REF.gianetti.2010.2857">Gianetti et al 2010</a>, <a class="bk_pop" href="#kms.REF.sykiotis.2010b.15140">Sykiotis et al 2010b</a>, <a class="bk_pop" href="#kms.REF.chan.2011.e1771">Chan et al 2011</a>, <a class="bk_pop" href="#kms.REF.miraoui.2013.725">Miraoui et al 2013</a>]; this may be due to unknown environmental, epigenetic, or <a class="def" href="/books/n/gene/glossary/def-item/oligogenic/">oligogenic</a> factors.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (carriers) for an IGD-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an IGD-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><div id="kms.Carrier_Heterozygote_Detection"><h4>Carrier (Heterozygote) Detection</h4><p>Identification of heterozygotes requires prior identification of the IGD-related pathogenic variants in the family.</p></div></div><div id="kms.Risk_to_Family_Members__Indeterminat"><h3>Risk to Family Members &#x02014; Indeterminate or Oligogenic Inheritance</h3><p>The exact risk for IGD to the family members of a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (a single individual with a disorder in a family) with IGD of unknown cause or a proband with an indeterminate or <a class="def" href="/books/n/gene/glossary/def-item/oligogenic/">oligogenic</a> inheritance is uncertain but may be up to 50%.</p></div><div id="kms.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#kms.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="kms.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the IGD-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for IGD are possible.</p></div></div><div id="kms.Resources"><h2 id="_kms_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Pituitary Network Association</b></div><div>PO Box 1958</div><div>Thousand Oaks CA 91358</div><div><b>Phone:</b> 805-499-9973</div><div><b>Fax:</b> 805-480-0633</div><div><b>Email:</b> info@pituitary.org</div><div><a href="http://pituitary.org/knowledge-base/disorders/hypogonadism" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hypogonadism</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Kallmann%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Kallmann syndrome</a></div></li><li class="half_rhythm"><div><b>Pituitary Foundation</b></div><div>PO Box 1944</div><div>Bristol BS99 2UB</div><div>United Kingdom</div><div><b>Phone:</b> 0845 450 0375 (Helpline); 0845 450 0376</div><div><b>Fax:</b> 0117 933 0910</div><div><b>Email:</b> helpline@pituitary.org.uk</div><div><a href="http://www.pituitary.org.uk/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.pituitary.org.uk</a></div></li><li class="half_rhythm"><div><b>The Pituitary Society</b></div><div>VA Medical Center</div><div>423 East 23rd Street</div><div>Room 16048aW</div><div>New York NY 10010</div><div><b>Phone:</b> 212-951-7035</div><div><b>Fax:</b> 212-951-7050</div><div><a href="https://pituitarysociety.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.pituitarysociety.org</a></div></li></ul></div><div id="kms.Molecular_Genetics"><h2 id="_kms_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="kms.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1334/table/kms.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kms.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3730" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ANOS1</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3730" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xp22<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P23352" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Anosmin-1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/KAL1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KAL1 @ LOVD</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ANOS1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ANOS1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ANOS1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ANOS1</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/558" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>AXL</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=558" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19q13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P30530" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Tyrosine-protein kinase receptor UFO</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=AXL" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AXL</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=AXL[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AXL</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/285025" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CCDC141</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=285025" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q31<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q6ZP82" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Coiled-coil domain-containing protein 141</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CCDC141" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCDC141</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CCDC141[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCDC141</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/55636" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CHD7</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=55636" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8q12<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9P2D1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Chromodomain-helicase-DNA-binding protein 7</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CHD7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHD7</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CHD7[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHD7</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1848" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>DUSP6</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1848" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q21<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q16828" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dual specificity protein phosphatase 6</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=DUSP6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DUSP6</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=DUSP6[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DUSP6</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/389549" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FEZF1</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=389549" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q31<wbr style="display:inline-block"></wbr>​.32</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/A0PJY2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Fez family zinc finger protein 1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FEZF1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FEZF1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FEZF1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FEZF1</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2253" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FGF8</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2253" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q24<wbr style="display:inline-block"></wbr>​.32</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P55075" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Fibroblast growth factor 8</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FGF8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGF8 database</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FGF8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGF8</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FGF8[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGF8</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8822" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FGF17</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8822" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8p21<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O60258" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Fibroblast growth factor 17</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FGF17" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGF17</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FGF17[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGF17</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2260" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FGFR1</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2260" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8p11<wbr style="display:inline-block"></wbr>​.23</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P11362" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Fibroblast growth factor receptor 1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FGFR1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR1 database</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FGFR1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FGFR1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR1</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/23767" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FLRT3</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=23767" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">20p12<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9NZU0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Leucine-rich repeat transmembrane protein FLRT3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FLRT3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLRT3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FLRT3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLRT3</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2796" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GNRH1</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2796" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8p21<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P01148" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Progonadoliberin-1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GNRH1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GNRH1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GNRH1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GNRH1</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2798" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GNRHR</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2798" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">4q13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P30968" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Gonadotropin-releasing hormone receptor</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/GNRHR" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GNRHR database</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GNRHR" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GNRHR</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GNRHR[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GNRHR</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9394" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>HS6ST1</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9394" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q14<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O60243" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Heparan-sulfate 6-O-sulfotransferase 1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HS6ST1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HS6ST1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=HS6ST1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HS6ST1</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/54756" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>IL17RD</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=54756" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3p14<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8NFM7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Interleukin-17 receptor D</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=IL17RD" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IL17RD</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=IL17RD[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IL17RD</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3814" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KISS1</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3814" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q32<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q15726" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Metastasis-suppressor KiSS-1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KISS1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KISS1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KISS1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KISS1</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/84634" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KISS1R</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=84634" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19p13<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q969F8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KiSS-1 receptor</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/KISS1R" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KISS1R database</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KISS1R" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KISS1R</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KISS1R[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KISS1R</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/26012" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>NSMF</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=26012" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q34<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q6X4W1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NMDA receptor synaptonuclear signaling and neuronal migration factor</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/NSMF" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NSMF database</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=NSMF" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NSMF</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NSMF[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NSMF</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/55703" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>POLR3B</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=55703" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q23<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9NW08" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DNA-directed RNA polymerase III subunit RPC2</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/POLR3B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">POLR3B @ LOVD</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=POLR3B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">POLR3B</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=POLR3B[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">POLR3B</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/60675" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PROK2</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=60675" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3p13</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9HC23" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Prokineticin-2</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/PROK2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PROK2 database</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PROK2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PROK2</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PROK2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PROK2</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/128674" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PROKR2</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=128674" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">20p12<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8NFJ6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Prokineticin receptor 2</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/PROKR2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PROKR2 database</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PROKR2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PROKR2</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PROKR2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PROKR2</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10371" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SEMA3A</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10371" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q21<wbr style="display:inline-block"></wbr>​.11</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q14563" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Semaphorin-3A</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SEMA3A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SEMA3A</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SEMA3A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SEMA3A</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9723" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SEMA3E</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9723" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q21<wbr style="display:inline-block"></wbr>​.11</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O15041" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Semaphorin-3E</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SEMA3E" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SEMA3E database</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SEMA3E" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SEMA3E</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SEMA3E[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SEMA3E</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6663" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SOX10</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6663" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q13<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P56693" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Transcription factor SOX-10</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.molgen.ua.ac.be/CMTMutations/Mutations/Contexts.cfm?ID=15" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IPN Mutations, SOX10</a><br /><a href="https://databases.lovd.nl/shared/genes/SOX10" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SOX10 homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SOX10" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SOX10</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SOX10[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SOX10</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/81848" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SPRY4</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=81848" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q31<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9C004" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Protein sprouty homolog 4</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SPRY4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPRY4</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SPRY4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPRY4</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10011" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SRA1</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10011" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q31<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9HD15" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Steroid receptor RNA activator 1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SRA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SRA1</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SRA1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SRA1</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6866" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TAC3</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6866" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q13<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UHF0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Tachykinin-3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TAC3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TAC3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TAC3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TAC3</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6870" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TACR3</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6870" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">4q24</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P29371" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Neuromedin-K receptor</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/TACR3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TACR3 database</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TACR3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TACR3</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TACR3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TACR3</a></td></tr><tr><td headers="hd_b_kms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/55717" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>WDR11</i></a></td><td headers="hd_b_kms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=55717" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q26<wbr style="display:inline-block"></wbr>​.12</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9BZH6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WD repeat-containing protein 11</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/WDR11" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WDR11 database</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=WDR11" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WDR11</a></td><td headers="hd_b_kms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=WDR11[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WDR11</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="kms.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="kms.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency (<a href="/omim/109135,136350,138850,146110,147950,152760,162330,162332,244200,300836,308700,600483,602229,602748,603286,603725,603819,603961,604161,604808,604846,606417,606807,607002,607123,607984,608137,608166,608892,610628,612370,612702,613301,614366,614381,614837,614838,614839,614840,614841,614842,614858,614880,614897,615266,615267,615269,615270,615271,616030,616031" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1334/table/kms.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kms.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/109135" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">109135</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">AXL RECEPTOR TYROSINE KINASE; AXL</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/136350" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">136350</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBROBLAST GROWTH FACTOR RECEPTOR 1; FGFR1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/138850" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">138850</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GONADOTROPIN-RELEASING HORMONE RECEPTOR; GNRHR</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/146110" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">146110</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/147950" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">147950</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA; HH2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/152760" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">152760</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GONADOTROPIN-RELEASING HORMONE 1; GNRH1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/162330" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">162330</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TACHYKININ 3; TAC3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/162332" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">162332</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TACHYKININ RECEPTOR 3; TACR3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/244200" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">244200</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300836" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300836</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KAL1 GENE; KAL1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/308700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">308700</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600483" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600483</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBROBLAST GROWTH FACTOR 8; FGF8</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602229" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602229</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SRY-BOX 10; SOX10</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602748" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602748</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DUAL-SPECIFICITY PHOSPHATASE 6; DUSP6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603286" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603286</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KISS1 METASTASIS SUPPRESSOR; KISS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603725" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603725</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBROBLAST GROWTH FACTOR 17; FGF17</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603819" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603819</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">STEROID RECEPTOR RNA ACTIVATOR 1; SRA1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603961" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603961</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SEMAPHORIN 3A; SEMA3A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604161" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604161</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KISS1 RECEPTOR; KISS1R</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604808" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604808</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 3; FLRT3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604846" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604846</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HEPARAN SULFATE 6-O-SULFOTRANSFERASE 1; HS6ST1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606417" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606417</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">WD REPEAT-CONTAINING PROTEIN 11; WDR11</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606807" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606807</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">INTERLEUKIN 17 RECEPTOR D; IL17RD</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607002" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607002</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PROKINETICIN 2; PROK2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607123" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607123</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PROKINETICIN RECEPTOR 2; PROKR2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607984" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607984</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPROUTY RTK SIGNALING ANTAGONIST 4; SPRY4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608137" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608137</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NMDA RECEPTOR SYNAPTONUCLEAR SIGNALING AND NEURONAL MIGRATION FACTOR; NSMF</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608166" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608166</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SEMAPHORIN 3E; SEMA3E</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608892" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608892</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 7; CHD7</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610628" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610628</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612370" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612370</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA; HH5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612702" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612702</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613301" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613301</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FEZ FAMILY ZINC FINGER PROTEIN 1; FEZF1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614366" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614366</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POLYMERASE III, RNA, SUBUNIT B; POLR3B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614381" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614381</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614837" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614837</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614838" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614838</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614839" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614839</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA; HH10</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614840" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614840</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614841" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614841</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA; HH12</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614842" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614842</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA; HH13</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614858" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614858</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614880" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614880</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA; HH15</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614897" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614897</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615266" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615266</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615267" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615267</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615269" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615269</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615270" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615270</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615271" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615271</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616030" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616030</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA; HH22</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616031" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616031</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COILED-COIL DOMAIN-CONTAINING PROTEIN 141; CCDC141</td></tr></tbody></table></div></div><div id="kms.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Over the last three decades, a combination of clinical investigational strategies and contemporary genetic approaches has revealed more than 25 causal/contributory genes for the nonsyndromic forms of IGD, with varied modes of inheritance. Broadly, two groups of genetic pathways are linked to IGD: (i) Neurodevelopmental genes govern the origin of the GnRH neurons and typically cause the Kallmann syndrome (KS) form of IGD. (ii) A group of neuroendocrine genes that control the secretion or action of GnRH cause the normosmic <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> GnRH deficiency (nIGD) form IGD. A small subset of genes may cause both KS and nIGD forms of IGD and this suggests that they govern both GnRH migration and GnRH secretion/action. (see <a class="figpopup" href="/books/NBK1334/table/kms.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figkmsTmoleculargenetictestingusedin" rid-ob="figobkmsTmoleculargenetictestingusedin">Table 2a</a> and <a class="figpopup" href="/books/NBK1334/table/kms.T.molecular_genetics_of_isolated_gon/?report=objectonly" target="object" rid-figpopup="figkmsTmoleculargeneticsofisolatedgon" rid-ob="figobkmsTmoleculargeneticsofisolatedgon">Table 2b</a>).</p><p>In addition to Mendelian modes of inheritance, a complex genetic architecture for IGD (occurring in 10%-15% of cases) has now been documented wherein pathogenic variants in two or more IGD-related genes are present in a single individual. These pathogenic variants are typically <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and by themselves are not sufficient to cause IGD but require the presence of additional pathogenic variants in a second <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> to cause IGD [<a class="bk_pop" href="#kms.REF.sykiotis.2010b.15140">Sykiotis et al 2010b</a>]. Almost all of the known IGD-related genes have been associated with <a class="def" href="/books/n/gene/glossary/def-item/oligogenic/">oligogenic</a> inheritance. These oligogenic pathogenic variants presumably act in a synergistic manner, potentially accounting for some of the <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> and incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> that is characteristic of IGD.</p><div id="kms.ANOS1_KAL1"><h4><i>ANOS1</i> (<i>KAL1</i>)</h4><p><b>Gene structure.</b>
<i>ANOS1</i> (<i>KAL1</i>) comprises 14 exons and has no alternative spice variants.</p><p><b>Pathogenic variants.</b> Reported pathogenic variants in <i>ANOS1</i> include <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, deletion of one or more exons, deletion of several nucleotides, pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, and splice variants. For more information, see <a href="/books/NBK1334/#kms.molgen.TA">Table A</a>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein encoded by <i>ANOS1</i>, anosmin 1, has 680 amino acids with functional similarities to molecules involved in neural development [<a class="bk_pop" href="#kms.REF.rugarli.1993.19">Rugarli et al 1993</a>]. The N-terminus domains share homologies with a consensus sequence of the whey acid protein family and a motif found in protease inhibitors. The C terminus contains a series of fibronectin type III repeats similar to those found in neural cell adhesion molecules.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Impaired function of anosmin results in a migratory defect of the olfactory and GnRH neurons from the olfactory placode during development [<a class="bk_pop" href="#kms.REF.cariboni.2004.2781">Cariboni et al 2004</a>]. The obstructed migration of these neurons accounts for the tell-tale signs of KS, IGD, and anosmia, and leads to olfactory bulb malformation detectable by MRI in the majority of individuals.</p></div><div id="kms.CHD7"><h4><i>CHD7</i></h4><p><b>Gene structure.</b>
<i>CHD7</i> comprises 38 exons.</p><p><b>Pathogenic variants.</b> Pathogenic variants of <i>CHD7</i> resulting in IGD are predominantly <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that are either <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> alleles or dominant alleles; in contrast, <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> (i.e., truncating) pathogenic variants in <i>CHD7</i> lead to a more extensive phenotypic presentation as seen in individuals with <a href="/books/n/gene/charge/">CHARGE syndrome</a> [<a class="bk_pop" href="#kms.REF.balasubramanian.2014.17953">Balasubramanian et al 2014</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The normal gene product is chromodomain helicase DNA-binding protein 7. It belongs to a family of proteins that are thought to alter nucleosome structures and mediate chromatin interactions.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>CHD7</i> pathogenic variants reported in individuals with KS or nIGD result in truncated proteins or amino acid substitutions of conserved residues when compared with CHD7 orthologs [<a class="bk_pop" href="#kms.REF.kim.2008.511">Kim et al 2008</a>].</p></div><div id="kms.FGFR1"><h4><i>FGFR1</i></h4><p><b>Gene structure.</b>
<i>FGFR1</i> comprises 18 exons with a known splice variant at the end of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 10.</p><p><b>Pathogenic variants.</b> Pathogenic variants in <i>FGFR1</i> include pathogenic deletions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and splice variants. For more information, see <a href="/books/NBK1334/#kms.molgen.TA">Table A</a>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>FGFR1</i> encodes a membrane receptor with three extracellular immunoglobulin-like domains and an intracellular tyrosine kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#kms.REF.lee.1989.57">Lee et al 1989</a>]. Ligand binding results in receptor dimerization and recruitment of intracellular signaling proteins.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Abnormal <i>FGFR1</i> gene products result in impaired receptor signaling. The gene dose effect of anosmin and its interaction with <i>FGFR1</i> in guiding GnRH neuronal migration have been proposed as explanations for the greater predominance of the IGD <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in males than females [<a class="bk_pop" href="#kms.REF.dod_.2003.463">Dod&#x000e9; et al 2003</a>].</p></div><div id="kms.GNRHR"><h4><i>GNRHR</i></h4><p><b>Gene structure.</b>
<i>GNRHR</i> comprises three coding exons and one alternative splice variant.</p><p><b>Pathogenic variants.</b>
<i>GNRHR</i> pathogenic variants, typically <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, cause normosmic IGD in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance pattern. Other pathogenic variants in <i>GNRHR</i> include <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and frameshift variants that occasionally cause autosomal recessive IGD. Heterozygous pathogenic variants (missense, frameshift, and nonsense) are also seen in persons with IGD with diverse clinical phenotypes, suggesting an <a class="def" href="/books/n/gene/glossary/def-item/oligogenic/">oligogenic</a> inheritance pattern [<a class="bk_pop" href="#kms.REF.gianetti.2012.e1798">Gianetti et al 2012</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>GNRHR</i> encodes for the gonadotropin-releasing hormone receptor, GNRHR, a G protein-coupled transmembrane receptor for the decapeptide, GNRH.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Abnormal <i>GNRHR</i> gene products result in diminished or absent GNRH signaling through the receptor resulting in hypogonadotropism.</p></div><div id="kms.IL17RD"><h4><i>IL17RD</i></h4><p><b>Gene structure.</b>
<i>IL17RD</i> comprises 17 coding exons and seven alternative splice variants.</p><p><b>Pathogenic variants.</b>
<i>IL17RD</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in both <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> and <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state cause the KS form of IGD, including <a class="def" href="/books/n/gene/glossary/def-item/oligogenic/">oligogenic</a> inheritance.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> This gene encodes a membrane protein that belongs to the interleukin-17 receptor (IL-17R) protein family and is the component of the interleukin-17 receptor signaling complex. The gene product affects fibroblast growth factor signaling, inhibiting or stimulating growth through MAPK/ERK signaling.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Abnormal <i>IL17RD</i> gene product results in increased FGF8 signaling in vitro, resulting in apoptosis of olfactory progenitor cells.</p></div><div id="kms.PROKR2"><h4><i>PROKR2</i></h4><p><b>Gene structure.</b>
<i>PROKR2</i> comprises two exons.</p><p><b>Pathogenic variants.</b> Pathogenic variants of <i>PROKR2</i> described include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The normal gene product encodes the prokineticin receptor 2, a G protein-coupled transmembrane receptor for PROK2.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>PROKR2</i> pathogenic variants identified in individuals with KS/nIGD result in diminished receptor function and impaired signaling [<a class="bk_pop" href="#kms.REF.cole.2008.3551">Cole et al 2008</a>, <a class="bk_pop" href="#kms.REF.monnier.2009.75">Monnier et al 2009</a>, <a class="bk_pop" href="#kms.REF.martin.2011.225">Martin et al 2011</a>]. Functional studies of selected <i>PROKR2</i> pathogenic variants have failed to demonstrate a dominant negative effect. Knockout mice lack olfactory bulbs and have severe atrophy of the reproductive system related to the absence of gonadotropin-releasing hormone (Gnrh)-synthesizing neurons in the hypothalamus [<a class="bk_pop" href="#kms.REF.matsumoto.2006.4140">Matsumoto et al 2006</a>, <a class="bk_pop" href="#kms.REF.martin.2011.225">Martin et al 2011</a>].</p></div><div id="kms.SOX10"><h4><i>SOX10</i></h4><p><b>Gene structure.</b>
<i>SOX10</i> comprises four coding exons and four alternative splice variants.</p><p><b>Pathogenic variants.</b>
<i>SOX10</i> <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, frameshift, or <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants cause the KS form of IGD in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pattern with variable <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SOX10</i> encodes a <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a>, SRY (sex determining region Y)-box 10 which is involved in the regulation of neural crest and peripheral nervous system development.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Abnormal <i>SOX10</i> gene products resulting in transcriptional activity and <i>Sox10</i>-deficient mice show impaired development of olfactory ensheathing cells and impaired migration of GnRH neurons.</p></div><div id="kms.TACR3"><h4><i>TACR3</i></h4><p><b>Gene structure.</b>
<i>TACR3</i> comprises five coding exons and no alternative splice variants.</p><p><b>Pathogenic variants.</b>
<i>TACR3</i> <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, frameshift, or <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants cause normosmic IGD in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance pattern. Occasionally, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants are also seen in persons with IGD, suggesting an <a class="def" href="/books/n/gene/glossary/def-item/oligogenic/">oligogenic</a> inheritance pattern.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>TACR3</i> encodes for TACR3, a G protein-coupled transmembrane receptor for neurokinin B.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Abnormal <i>TACR3</i> gene products result in diminished or absent neurokinin B signaling through the receptor, resulting in secondary GnRH deficiency and consequent hypogonadotropism.</p><p>For information about genes in <a class="figpopup" href="/books/NBK1334/table/kms.T.molecular_genetics_of_isolated_gon/?report=objectonly" target="object" rid-figpopup="figkmsTmoleculargeneticsofisolatedgon" rid-ob="figobkmsTmoleculargeneticsofisolatedgon">Table 2b</a>, click <a href="/books/NBK1334/bin/kms-less_common_genes.pdf">here</a> (pdf).</p></div></div></div><div id="kms.References"><h2 id="_kms_References_">References</h2><div id="kms.Published_Guidelines__Consensus_Stat"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="kms.REF.boehm.2015">Boehm U, Bouloux PM, Dattani MT, de Roux N, Dod&#x000e9; C, Dunkel L, Dwyer AA, Giacobini P, Hardelin JP, Juul A, Maghnie M, Pitteloud N, Prevot V, Raivio T, Tena-Sempere M, Quinton R, Young J. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Available <a href="http://www.nature.com/nrendo/journal/v11/n9/full/nrendo.2015.112.html" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2015. Accessed 10-17-18. [<a href="/pubmed/26194704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26194704</span></a>]</div></li></ul></div><div id="kms.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="kms.REF.au.2011.102">Au MG, Crowley WF Jr, Buck CL. Genetic counseling for isolated GnRH deficiency. <span><span class="ref-journal">Mol Cell Endocrinol. </span>2011;<span class="ref-vol">346</span>:102–9.</span> [<a href="/pmc/articles/PMC3185214/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3185214</span></a>] [<a href="/pubmed/21664415" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21664415</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.balasubramanian.2014.17953">Balasubramanian R, Choi JH, Francescatto L, Willer J, Horton ER, Asimacopoulos EP, Stankovic KM, Plummer L, Buck CL, Quinton R, Nebesio TD, Mericq V, Merino PM, Meyer BF, Monies D, Gusella JF, Al Tassan N, Katsanis N, Crowley WF Jr. Functionally compromised CHD7 alleles in patients with isolated GnRH deficiency. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2014;<span class="ref-vol">111</span>:17953–8.</span> [<a href="/pmc/articles/PMC4273325/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4273325</span></a>] [<a href="/pubmed/25472840" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25472840</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.balasubramanian.2015.e473">Balasubramanian R, Chew S, MacKinnon SE, Kang PB, Andrews C, Chan WM, Engle EC. Expanding the phenotypic spectrum and variability of endocrine abnormalities associated with TUBB3 E410K syndrome. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2015;<span class="ref-vol">100</span>:E473–7.</span> [<a href="/pmc/articles/PMC4333039/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4333039</span></a>] [<a href="/pubmed/25559402" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25559402</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.b_d_carrats.2007.368">B&#x000e9;d&#x000e9;carrats GY, Kaiser UB. Mutations in the human gonadotropin-releasing hormone receptor: insights into receptor biology and function. <span><span class="ref-journal">Semin Reprod Med. </span>2007;<span class="ref-vol">25</span>:368–78.</span> [<a href="/pubmed/17710733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17710733</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.bianco.2009.569">Bianco SD, Kaiser UB. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. <span><span class="ref-journal">Nat Rev Endocrinol. </span>2009;<span class="ref-vol">5</span>:569–76.</span> [<a href="/pmc/articles/PMC2864719/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2864719</span></a>] [<a href="/pubmed/19707180" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19707180</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.bick.1989.100">Bick D, Curry CJ, McGill JR, Schorderet DF, Bux RC, Moore CM. Male infant with ichthyosis, Kallmann syndrome, chondrodysplasia punctata, and an Xp chromosome deletion. <span><span class="ref-journal">Am J Med Genet. </span>1989;<span class="ref-vol">33</span>:100–7.</span> [<a href="/pubmed/2750777" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2750777</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.binabbas.1999.579">Bin-Abbas B, Conte FA, Grumbach MM, Kaplan SL. Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size why sex reversal is not indicated. <span><span class="ref-journal">J Pediatr. </span>1999;<span class="ref-vol">134</span>:579–83.</span> [<a href="/pubmed/10228293" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10228293</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.boehm.2015.547">Boehm U, Bouloux PM, Dattani MT, de Roux N, Dod&#x000e9; C, Dunkel L, Dwyer AA, Giacobini P, Hardelin JP, Juul A, Maghnie M, Pitteloud N, Prevot V, Raivio T, Tena-Sempere M, Quinton R, Young J. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. <span><span class="ref-journal">Nat Rev Endocrinol. </span>2015;<span class="ref-vol">11</span>:547–64.</span> [<a href="/pubmed/26194704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26194704</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.bouligand.2009.2742">Bouligand J, Ghervan C, Tello JA, Brailly-Tabard S, Salenave S, Chanson P, Lomb&#x000e8;s M, Millar RP, Guiochon-Mantel A, Young J. Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">360</span>:2742–8.</span> [<a href="/pubmed/19535795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19535795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.burris.1988.1144">Burris AS, Rodbard HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>1988;<span class="ref-vol">66</span>:1144–51.</span> [<a href="/pubmed/3372679" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3372679</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.cariboni.2011.336">Cariboni A, Davidson K, Rakic S, Maggi R, Parnavelas JG, Ruhrberg C. Defective gonadotropin-releasing hormone neuron migration in mice lacking SEMA3A signalling through NRP1 and NRP2: implications for the aetiology of hypogonadotropic hypogonadism. <span><span class="ref-journal">Hum Mol Genet. </span>2011;<span class="ref-vol">20</span>:336–44.</span> [<a href="/pubmed/21059704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21059704</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.cariboni.2004.2781">Cariboni A, Pimpinelli F, Colamarino S, Zaninetti R, Piccolella M, Rumio C, Piva F, Rugarli EI, Maggi R. The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons. <span><span class="ref-journal">Hum Mol Genet. </span>2004;<span class="ref-vol">13</span>:2781–91.</span> [<a href="/pubmed/15471890" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15471890</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.cariboni.2015.2413">Cariboni A, Andr&#x000e9; V, Chauvet S, Cassatella D, Davidson K, Caramello A, Fantin A, Bouloux P, Mann F, Ruhrberg C. Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome. <span><span class="ref-journal">J Clin Invest. </span>2015;<span class="ref-vol">125</span>:2413–28.</span> [<a href="/pmc/articles/PMC4497752/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4497752</span></a>] [<a href="/pubmed/25985275" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25985275</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.cassidy.2012.10">Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi Syndrome. <span><span class="ref-journal">Genet Med. </span>2012;<span class="ref-vol">14</span>:10–26.</span> [<a href="/pubmed/22237428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22237428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.cerrato.2006.s3">Cerrato F, Shagoury J, Kralickova M, Dwyer A, Falardeau J, Ozata M, Van Vliet G, Bouloux P, Hall JE, Hayes FJ, Pitteloud N, Martin KA, Welt C, Seminara SB. Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism. <span><span class="ref-journal">Eur J Endocrinol. </span>2006 Nov;<span class="ref-vol">155</span> Suppl 1:S3–S10.</span> [<a href="/pubmed/17074994" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17074994</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.chan.2011.e1771">Chan YM, Broder-Fingert S, Paraschos S, Lapatto R, Au M, Hughes V, Bianco SD, Min L, Plummer L, Cerrato F, De Guillebon A, Wu IH, Wahab F, Dwyer A, Kirsch S, Quinton R, Cheetham T, Ozata M, Ten S, Chanoine JP, Pitteloud N, Martin KA, Schiffmann R, Van der Kamp HJ, Nader S, Hall JE, Kaiser UB, Seminara SB. GnRH-deficient phenotypes in humans and mice with heterozygous variants in KISS1/Kiss1. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2011;<span class="ref-vol">96</span>:E1771–81.</span> [<a href="/pmc/articles/PMC3205899/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3205899</span></a>] [<a href="/pubmed/21880801" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21880801</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.chan.2009.11703">Chan YM, de Guillebon A, Lang-Muritano M, Plummer L, Cerrato F, Tsiaras S, Gaspert A, Lavoie HB, Wu CH, Crowley WF Jr, Amory JK, Pitteloud N, Seminara SB. GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2009;<span class="ref-vol">106</span>:11703–8.</span> [<a href="/pmc/articles/PMC2710623/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2710623</span></a>] [<a href="/pubmed/19567835" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19567835</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.chew.2013.522">Chew S, Balasubramanian R, Chan WM, Kang PB, Andrews C, Webb BD, MacKinnon SE, Oystreck DT, Rankin J, Crawford TO, Geraghty M, Pomeroy SL, Crowley WF Jr, Jabs EW, Hunter DG, Grant PE, Engle EC. A novel syndrome caused by the E410K amino acid substitution in the neuronal &#x003b2;-tubulin isotype 3. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:522–35.</span> [<a href="/pmc/articles/PMC3572929/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3572929</span></a>] [<a href="/pubmed/23378218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23378218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.cl_ment.1998.398">Cl&#x000e9;ment K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougn&#x000e8;res P, Lebouc Y, Froguel P, Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. <span><span class="ref-journal">Nature. </span>1998;<span class="ref-vol">392</span>:398–401.</span> [<a href="/pubmed/9537324" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9537324</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.cole.2008.3551">Cole LW, Sidis Y, Zhang C, Quinton R, Plummer L, Pignatelli D, Hughes VA, Dwyer AA, Ravio T, Hayes FJ, Seminara SB, Huot C, Alos N, Speiser P, Takeshita A, Van Vliet G, Pearce S, Crowley WF Jr, Zhou QY, Pitteloud N. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotropin-releasing hormone deficiency: molecular genetics and clinical spectrum. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2008;<span class="ref-vol">93</span>:3551–9.</span> [<a href="/pmc/articles/PMC2567850/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2567850</span></a>] [<a href="/pubmed/18559922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18559922</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.costabarbosa.2013.e943">Costa-Barbosa FA, Balasubramanian R, Keefe KW, Shaw ND, Al-Tassan N, Plummer L, Dwyer A, Buck CL, Choi J-H, Seminara SB, Quinton R, Monies D, Meyer B, Hall JE, Pitteloud N, Crowley WF. Prioritizing Genetic Testing in Patients With Kallmann Syndrome Using Clinical Phenotypes. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2013;<span class="ref-vol">98</span>:E943–53.</span> [<a href="/pmc/articles/PMC3644607/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3644607</span></a>] [<a href="/pubmed/23533228" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23533228</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.crowley.1985.473">Crowley WF Jr, Filicori M, Spratt DI, Santoro NF. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. <span><span class="ref-journal">Recent Prog Horm Res. </span>1985;<span class="ref-vol">41</span>:473–531.</span> [<a href="/pubmed/3931190" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3931190</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.de_roux.2003.10972">de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2003;<span class="ref-vol">100</span>:10972–6.</span> [<a href="/pmc/articles/PMC196911/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC196911</span></a>] [<a href="/pubmed/12944565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12944565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.de_roux.1997.1597">de Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G, Milgrom E. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. <span><span class="ref-journal">N Engl J Med. </span>1997;<span class="ref-vol">337</span>:1597–602.</span> [<a href="/pubmed/9371856" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9371856</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.degros.2003.23">Degros V, Cortet-Rudelli C, Soudan B, Dewailly D. The human chorionic gonadotropin test is more powerful than the gonadotropin-releasing hormone agonist test to discriminate male isolated hypogonadotropic hypogonadism from constitutional delayed puberty. <span><span class="ref-journal">Eur J Endocrinol. </span>2003;<span class="ref-vol">149</span>:23–9.</span> [<a href="/pubmed/12824862" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12824862</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.dod_.2003.463">Dod&#x000e9; C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Soussi-Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, Pecheux C, Le Tessier D, Cruaud C, Delpech M, Speleman F, Vermeulen S, Amalfitano A, Bachelot Y, Bouchard P, Cabrol S, Carel JC, Delemarre-van de Waal H, Goulet-Salmon B, Kottler ML, Richard O, Sanchez-Franco F, Saura R, Young J, Petit C, Hardelin JP. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">33</span>:463–5.</span> [<a href="/pubmed/12627230" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12627230</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.doty.2007.460">Doty RL. Office procedures for quantitative assessment of olfactory function. <span><span class="ref-journal">Am J Rhinol. </span>2007;<span class="ref-vol">21</span>:460–73.</span> [<a href="/pubmed/17882917" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17882917</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.dwyer.2013.e1790">Dwyer AA, Sykiotis GP, Hayes FJ, Boepple PA, Lee H, Loughlin KR, Dym M, Sluss PM, Crowley WF Jr, Pitteloud N. Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2013;<span class="ref-vol">98</span>:E1790–5.</span> [<a href="/pmc/articles/PMC3816270/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3816270</span></a>] [<a href="/pubmed/24037890" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24037890</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.falardeau.2008.2822">Falardeau J, Chung WC, Beenken A, Raivio T, Plummer L, Sidis Y, Jacobson-Dickman EE, Eliseenkova AV, Ma J, Dwyer A, Quinton R, Na S, Hall JE, Huot C, Alois N, Pearce SH, Cole LW, Hughes V, Mohammadi M, Tsai P, Pitteloud N. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. <span><span class="ref-journal">J Clin Invest. </span>2008;<span class="ref-vol">118</span>:2822–31.</span> [<a href="/pmc/articles/PMC2441855/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2441855</span></a>] [<a href="/pubmed/18596921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18596921</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.gianetti.2012.e1798">Gianetti E, Hall JE, Au MG, Kaiser UB, Quinton R, Stewart JA, Metzger DL, Pitteloud N, Mericq V, Merino PM, Levitsky LL, Izatt L, Lang-Muritano M, Fujimoto VY, Dluhy RG, Chase ML, Crowley WF Jr, Plummer L, Seminara SB. When genetic load does not correlate with phenotypic spectrum: lessons from the GnRH receptor (GNRHR). <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2012;<span class="ref-vol">97</span>:E1798–807.</span> [<a href="/pmc/articles/PMC3431570/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3431570</span></a>] [<a href="/pubmed/22745237" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22745237</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.gianetti.2010.2857">Gianetti E, Tusset C, Noel SD, Au MG, Dwyer AA, Hughes VA, Abreu AP, Carroll J, Trarbach E, Silveira LF, Costa EM, de Mendon&#x000e7;a BB, de Castro M, Lofrano A, Hall JE, Bolu E, Ozata M, Quinton R, Amory JK, Stewart SE, Arlt W, Cole TR, Crowley WF, Kaiser UB, Latronico AC, Seminara SB. TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2010;<span class="ref-vol">95</span>:2857–67.</span> [<a href="/pmc/articles/PMC2902066/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2902066</span></a>] [<a href="/pubmed/20332248" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20332248</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.grumbach.2005.3122">Grumbach MM. A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2005;<span class="ref-vol">90</span>:3122–7.</span> [<a href="/pubmed/15728198" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15728198</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.guran.2009.3633">Guran T, Tolhurst G, Bereket A, Rocha N, Porter K, Turan S, Gribble FM, Kotan LD, Akcay T, Atay Z, Canan H, Serin A, O'Rahilly S, Reimann F, Semple RK, Topaloglu AK. Hypogonadotropic hypogonadism due to a novel missense mutation in the first extracellular loop of the neurokinin B receptor. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2009;<span class="ref-vol">94</span>:3633–9.</span> [<a href="/pmc/articles/PMC4306717/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4306717</span></a>] [<a href="/pubmed/19755480" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19755480</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.hanchate.2012.e1002896">Hanchate NK, Giacobini P, Lhuillier P, Parkash J, Espy C, Fouveaut C, Leroy C, Baron S, Campagne C, Vanacker C, Collier F, Cruaud C, Meyer V, Garc&#x000ed;a-Pi&#x000f1;ero A, Dewailly D, Cortet-Rudelli C, Gersak K, Metz C, Chabrier G, Pugeat M, Young J, Hardelin JP, Prevot V, Dod&#x000e9; C. SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome. <span><span class="ref-journal">PLoS Genet. </span>2012;<span class="ref-vol">8</span>:e1002896.</span> [<a href="/pmc/articles/PMC3426548/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3426548</span></a>] [<a href="/pubmed/22927827" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22927827</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.hipkin.1990.198">Hipkin LJ, Casson IF, Davis JC. Identical twins discordant for Kallmann's syndrome. <span><span class="ref-journal">J Med Genet. </span>1990;<span class="ref-vol">27</span>:198–9.</span> [<a href="/pmc/articles/PMC1017005/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1017005</span></a>] [<a href="/pubmed/2325096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2325096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.hoffman.1982.1237">Hoffman AR, Crowley WF Jr. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. <span><span class="ref-journal">N Engl J Med. </span>1982;<span class="ref-vol">307</span>:1237–41.</span> [<a href="/pubmed/6813732" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6813732</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.hou.2005.643">Hou JW. Detection of gene deletions in children with chondrodysplasia punctata, ichthyosis, Kallmann syndrome, and ocular albinism by FISH studies. <span><span class="ref-journal">Chang Gung Med J. </span>2005;<span class="ref-vol">28</span>:643–50.</span> [<a href="/pubmed/16323556" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16323556</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.hutchins.2016.1956">Hutchins BI, Kotan LD, Taylor-Burds C, Ozkan Y, Cheng PJ, Gurbuz F, Tiong JD, Mengen E, Yuksel B, Topaloglu AK, Wray S. CCDC141 Mutation Identified in Anosmic Hypogonadotropic Hypogonadism (Kallmann Syndrome) Alters GnRH Neuronal Migration. <span><span class="ref-journal">Endocrinology. </span>2016;<span class="ref-vol">157</span>:1956–66.</span> [<a href="/pmc/articles/PMC4870868/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4870868</span></a>] [<a href="/pubmed/27014940" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27014940</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.jackson.2003.1550">Jackson RS, Creemers JW, Farooqi IS, Raffin-Sanson ML, Varro A, Dockray GJ, Holst JJ, Brubaker PL, Corvol P, Polonsky KS, Ostrega D, Becker KL, Bertagna X, Hutton JC, White A, Dattani MT, Hussain K, Middleton SJ, Nicole TM, Milla PJ, Lindley KJ, O'Rahilly S. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. <span><span class="ref-journal">J Clin Invest. </span>2003;<span class="ref-vol">112</span>:1550–60.</span> [<a href="/pmc/articles/PMC259128/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC259128</span></a>] [<a href="/pubmed/14617756" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14617756</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.jackson.1997.303">Jackson RS, Creemers JW, Ohagi S, Raffin-Sanson ML, Sanders L, Montague CT, Hutton JC, O'Rahilly S. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. <span><span class="ref-journal">Nat Genet. </span>1997;<span class="ref-vol">16</span>:303–6.</span> [<a href="/pubmed/9207799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9207799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.jongmans.2009.65">Jongmans MC, van Ravenswaaij-Arts CM, Pitteloud N, Ogata T, Sato N, Claahsen-van der Grinten HL, van der Donk K, Seminara S, Bergman JE, Brunner HG, Crowley WF Jr, Hoefsloot LH. CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome. <span><span class="ref-journal">Clin Genet. </span>2009;<span class="ref-vol">75</span>:65–71.</span> [<a href="/pmc/articles/PMC2854009/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2854009</span></a>] [<a href="/pubmed/19021638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19021638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.kim.2010.465">Kim HG, Ahn JW, Kurth I, Ullmann R, Kim HT, Kulharya A, Ha KS, Itokawa Y, Meliciani I, Wenzel W, Lee D, Rosenberger G, et al.  WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">87</span>:465–79.</span> [<a href="/pmc/articles/PMC2948809/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2948809</span></a>] [<a href="/pubmed/20887964" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20887964</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.kim.2008.511">Kim HG, Kurth I, Lan F, Meliciani I, Wenzel W, Eom SH, Kang GB, Rosenberger G, Tekin M, Ozata M, Bick DP, Sherins RJ, Walker SL, Shi Y, Gusella JF, Layman LC. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">83</span>:511–9.</span> [<a href="/pmc/articles/PMC2561938/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2561938</span></a>] [<a href="/pubmed/18834967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18834967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.kotan.2014.326">Kotan LD, Hutchins BI, Ozkan Y, Demirel F, Stoner H, Cheng PJ, Esen I, Gurbuz F, Bicakci YK, Mengen E, Yuksel B, Wray S, Topaloglu AK. Mutations in FEZF1 cause Kallmann syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2014;<span class="ref-vol">95</span>:326–31.</span> [<a href="/pmc/articles/PMC4157145/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4157145</span></a>] [<a href="/pubmed/25192046" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25192046</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.kotan.2016.125">Kotan LD, Cooper C, Darcan &#x0015e;, Carr IM, &#x000d6;zen S, Yan Y, Hamedani MK, G&#x000fc;rb&#x000fc;z F, Mengen E, Turan &#x00130;, Ulubay A, Akku&#x0015f; G, Y&#x000fc;ksel B, Topalo&#x0011f;lu AK, Leygue E. Idiopathic Hypogonadotropic Hypogonadism Caused by Inactivating Mutations in SRA1. <span><span class="ref-journal">J Clin Res Pediatr Endocrinol. </span>2016;<span class="ref-vol">8</span>:125–34.</span> [<a href="/pmc/articles/PMC5096466/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5096466</span></a>] [<a href="/pubmed/27086651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27086651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.laitinen.2011.41">Laitinen EM, Vaaralahti K, Tommiska J, Eklund E, Tervaniemi M, Valanne L, Raivio T. Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2011;<span class="ref-vol">6</span>:41.</span> [<a href="/pmc/articles/PMC3143089/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3143089</span></a>] [<a href="/pubmed/21682876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21682876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.lalani.2009">Lalani SR, Belmont JW. CHARGE syndrome. In: Lang F, ed. <em>Encyclopedia of Molecular Mechanisms of Disease</em>. Springer Publishing House. 2009.</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.lee.1989.57">Lee PL, Johnson DE, Cousens LS, Fried VA, Williams LT. Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. <span><span class="ref-journal">Science. </span>1989;<span class="ref-vol">245</span>:57–60.</span> [<a href="/pubmed/2544996" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2544996</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.lewkowitzshpuntoff.2012.e136">Lewkowitz-Shpuntoff HM, Hughes VA, Plummer L, Au MG, Doty RL, Seminara SB, Chan YM, Pitteloud N, Crowley WF Jr, Balasubramanian R. Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2012;<span class="ref-vol">97</span>:E136–44.</span> [<a href="/pmc/articles/PMC3251934/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3251934</span></a>] [<a href="/pubmed/22072740" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22072740</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.liu.2009.801">Liu PY, Baker HW, Jayadev V, Zacharin M, Conway AJ, Handelsman DJ. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2009;<span class="ref-vol">94</span>:801–8.</span> [<a href="/pubmed/19066302" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19066302</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.mainieri.2003.307">Mainieri AS, Elnecave RH. Usefulness of the free alpha-subunit to diagnose hypogonadotropic hypogonadism. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2003;<span class="ref-vol">59</span>:307–13.</span> [<a href="/pubmed/12919153" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12919153</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.margolin.2013.1992">Margolin DH, Kousi M, Chan YM, Lim ET, Schmahmann JD, Hadjivassiliou M, Hall JE, Adam I, Dwyer A, Plummer L, Aldrin SV, O'Rourke J, Kirby A, Lage K, Milunsky A, Milunsky JM, Chan J, Hedley-Whyte ET, Daly MJ, Katsanis N, Seminara SB. Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. <span><span class="ref-journal">N Engl J Med. </span>2013;<span class="ref-vol">368</span>:1992–2003.</span> [<a href="/pmc/articles/PMC3738065/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3738065</span></a>] [<a href="/pubmed/23656588" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23656588</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.martin.2011.225">Martin C, Balasubramanian R, Dwyer AA, Au MG, Sidis Y, Kaiser UB, Seminara SB, Pitteloud N, Zhou QY, Crowley WF Jr. The Role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations. <span><span class="ref-journal">Endocr Rev. </span>2011;<span class="ref-vol">32</span>:225–46.</span> [<a href="/pmc/articles/PMC3365793/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3365793</span></a>] [<a href="/pubmed/21037178" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21037178</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.martin.1990">Martin K, Santoro N, Hall J, Filicori M, Wierman M, Crowley WF Jr (1990) Clinical review 15: Management of ovulatory disorders with pulsatile gonadotropin-releasing hormone. J Clin Endocrinol Metab. 71:1081A-G. [<a href="/pubmed/2229271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2229271</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.massin.2003.2003">Massin N, Pecheux C, Eloit C, Bensimon JL, Galey J, Kuttenn F, Hardelin JP, Dode C, Touraine P. X chromosome-linked Kallmann syndrome: clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2003;<span class="ref-vol">88</span>:2003–8.</span> [<a href="/pubmed/12727945" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12727945</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.matsumoto.2006.4140">Matsumoto S, Yamazaki C, Masumoto KH, Nagano M, Naito M, Soga T, Hiyama H, Matsumoto M, Takasaki J, Kamohara M, Matsuo A, Ishii H, Kobori M, Katoh M, Matsushime H, Furuichi K, Shigeyoshi Y. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2006;<span class="ref-vol">103</span>:4140–5.</span> [<a href="/pmc/articles/PMC1449660/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1449660</span></a>] [<a href="/pubmed/16537498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16537498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.matsuo.2000.783">Matsuo T, Okamoto S, Izumi Y, Hosokawa A, Takegawa T, Fukui H, Tun Z, Honda K, Matoba R, Tasumi K, Amino N. A novel mutation of the KAL1 gene in monozygotic twins with Kallmann syndrome. <span><span class="ref-journal">Eur J Endocrinol. </span>2000;<span class="ref-vol">143</span>:783–7.</span> [<a href="/pubmed/11124862" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11124862</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.miraoui.2013.725">Miraoui H, Dwyer AA, Sykiotis GP, Plummer L, Chung W, Feng B, Beenken A, Clarke J, Pers TH, Dworzynski P, Keefe K, Niedziela M, Raivio T, Crowley WF Jr, Seminara SB, Quinton R, Hughes VA, Kumanov P, Young J, Yialamas MA, Hall JE, Van Vliet G, Chanoine JP, Rubenstein J, Mohammadi M, Tsai PS, Sidis Y, Lage K, Pitteloud N. Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">92</span>:725–43.</span> [<a href="/pmc/articles/PMC3644636/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3644636</span></a>] [<a href="/pubmed/23643382" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23643382</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.monnier.2009.75">Monnier C, Dode C, Fabre L, Teixeira L, Labesse G, Pin JP, Hardelin JP, Rondard P. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:75–81.</span> [<a href="/pmc/articles/PMC3298864/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3298864</span></a>] [<a href="/pubmed/18826963" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18826963</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.nachtigall.1997.410">Nachtigall LB, Boepple PA, Pralong FP, Crowley WF Jr. Adult-onset idiopathic hypogonadotropic hypogonadism--a treatable form of male infertility. <span><span class="ref-journal">N Engl J Med. </span>1997;<span class="ref-vol">336</span>:410–5.</span> [<a href="/pubmed/9010147" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9010147</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.oliveira.2001.1532">Oliveira LM, Seminara SB, Beranova M, Hayes FJ, Valkenburgh SB, Schipani E, Costa EM, Latronico AC, Crowley WF Jr, Vallejo M. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2001;<span class="ref-vol">86</span>:1532–8.</span> [<a href="/pubmed/11297579" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11297579</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.pedersenwhite.2008.367">Pedersen-White JR, Chorich LP, Bick DP, Sherins RJ, Layman LC. The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. <span><span class="ref-journal">Mol Hum Reprod. </span>2008;<span class="ref-vol">14</span>:367–70.</span> [<a href="/pmc/articles/PMC2434956/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2434956</span></a>] [<a href="/pubmed/18463157" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18463157</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.pingault.2013.707">Pingault V, Bodereau V, Baral V, Marcos S, Watanabe Y, Chaoui A, Fouveaut C, Leroy C, V&#x000e9;rier-Mine O, Francannet C, Dupin-Deguine D, Archambeaud F, Kurtz FJ, Young J, Bertherat J, Marlin S, Goossens M, Hardelin JP, Dod&#x000e9; C, Bondurand N. Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">92</span>:707–24.</span> [<a href="/pmc/articles/PMC3644631/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3644631</span></a>] [<a href="/pubmed/23643381" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23643381</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.pinto.2005.5621">Pinto G, Abadie V, Mesnage R, Blustajn J, Cabrol S, Amiel J, Hertz-Pannier L, Bertrand AM, Lyonnet S, Rappaport R, Netchine I. CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2005;<span class="ref-vol">90</span>:5621–6.</span> [<a href="/pubmed/16030162" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16030162</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.pitteloud.2006a.6281">Pitteloud N, Acierno JS Jr, Meysing A, Eliseenkova AV, Ma J, Ibrahimi OA, Metzger DL, Hayes FJ, Dwyer AA, Hughes VA, Yialamas M, Hall JE, Grant E, Mohammadi M, Crowley WF Jr. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2006a;<span class="ref-vol">103</span>:6281–6.</span> [<a href="/pmc/articles/PMC1458869/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1458869</span></a>] [<a href="/pubmed/16606836" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16606836</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.pitteloud.2001.2470">Pitteloud N, Boepple PA, DeCruz S, Valkenburgh SB, Crowley WF Jr, Hayes FJ. The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2001;<span class="ref-vol">86</span>:2470–5.</span> [<a href="/pubmed/11397842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11397842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.pitteloud.2002a.152">Pitteloud N, Hayes FJ, Boepple PA, DeCruz S, Seminara SB, MacLaughlin DT, Crowley WF Jr. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2002a;<span class="ref-vol">87</span>:152–60.</span> [<a href="/pubmed/11788640" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11788640</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.pitteloud.2002b.4128">Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H, Crowley WF Jr. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2002b;<span class="ref-vol">87</span>:4128–36.</span> [<a href="/pubmed/12213860" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12213860</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.pitteloud.2006b.60">Pitteloud N, Meysing A, Quinton R, Acierno JS Jr, Dwyer AA, Plummer L, Fliers E, Boepple P, Hayes F, Seminara S, Hughes VA, Ma J, Bouloux P, Mohammadi M, Crowley WF Jr. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. <span><span class="ref-journal">Mol Cell Endocrinol. </span>2006b;<span class="ref-vol">254-255</span>:60–9.</span> [<a href="/pubmed/16764984" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16764984</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.quinton.2001.163">Quinton R, Duke VM, Robertson A, Kirk JM, Matfin G, de Zoysa PA, Azcona C, MacColl GS, Jacobs HS, Conway GS, Besser M, Stanhope RG, Bouloux PM. Idiopathic gonadotropin deficiency: genetic questions addressed through phenotypic characterization. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2001;<span class="ref-vol">55</span>:163–74.</span> [<a href="/pubmed/11531922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11531922</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.raivio.2007.863">Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, Hughes VA, Cole LW, Pearce SH, Lee H, Boepple P, Crowley WF Jr, Pitteloud N. Reversal of idiopathic hypogonadotropic hypogonadism. <span><span class="ref-journal">N Engl J Med. </span>2007;<span class="ref-vol">357</span>:863–73.</span> [<a href="/pubmed/17761590" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17761590</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.richards.2017.19">Richards MR, Plummer L, Chan YM, Lippincott MF, Quinton R, Kumanov P, Seminara SB. Phenotypic spectrum of POLR3B mutations: isolated hypogonadotropic hypogonadism without neurological or dental anomalies. <span><span class="ref-journal">J Med Genet. </span>2017;<span class="ref-vol">54</span>:19–25.</span> [<a href="/pmc/articles/PMC5189673/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5189673</span></a>] [<a href="/pubmed/27512013" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27512013</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.rugarli.1993.19">Rugarli EI, Lutz B, Kuratani SC, Wawersik S, Borsani G, Ballabio A, Eichele G. Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting. <span><span class="ref-journal">Nat Genet. </span>1993;<span class="ref-vol">4</span>:19–26.</span> [<a href="/pubmed/8513320" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8513320</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.salianmehta.2014.1452">Salian-Mehta S, Xu M, Knox AJ, Plummer L, Slavov D, Taylor M, Bevers S, Hodges RS, Crowley WF Jr, Wierman ME. Functional consequences of AXL sequence variants in hypogonadotropic hypogonadism. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2014;<span class="ref-vol">99</span>:1452–60.</span> [<a href="/pmc/articles/PMC3973777/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3973777</span></a>] [<a href="/pubmed/24476074" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24476074</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.santoro.1986.11">Santoro N, Filicori M, Crowley WF Jr. Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone. <span><span class="ref-journal">Endocr Rev. </span>1986;<span class="ref-vol">7</span>:11–23.</span> [<a href="/pubmed/3082615" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3082615</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.sato.2006.220">Sato N, Ogata T. Kallmann syndrome. <span><span class="ref-journal">Nihon Rinsho. </span>2006 Suppl 2:220–4.</span> [<a href="/pubmed/16817388" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16817388</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.segal.2009.780">Segal TY, Mehta A, Anazodo A, Hindmarsh PC, Dattani MT. Role of gonadotropin-releasing hormone and human chorionic gonadotropin stimulation tests in differentiating patients with hypogonadotropic hypogonadism from those with constitutional delay of growth and puberty. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2009;<span class="ref-vol">94</span>:780–5.</span> [<a href="/pubmed/19017752" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19017752</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.seminara.1998.521">Seminara SB, Hayes FJ, Crowley WF Jr. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. <span><span class="ref-journal">Endocr Rev. </span>1998;<span class="ref-vol">19</span>:521–39.</span> [<a href="/pubmed/9793755" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9793755</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.seminara.2002.1607">Seminara SB, Acierno JS Jr, Abdulwahid NA, Crowley WF Jr, Margolin DH. Hypogonadotropic hypogonadism and cerebellar ataxia: detailed phenotypic characterization of a large, extended kindred. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2002;<span class="ref-vol">87</span>:1607–12.</span> [<a href="/pubmed/11932290" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11932290</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.seminara.2003.1614">Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF Jr, Aparicio SA, Colledge WH. The GPR54 gene as a regulator of puberty. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">349</span>:1614–27.</span> [<a href="/pubmed/14573733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14573733</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.semple.2005.1849">Semple RK, Achermann JC, Ellery J, Farooqi IS, Karet FE, Stanhope RG, O'rahilly S, Aparicio SA. Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2005;<span class="ref-vol">90</span>:1849–55.</span> [<a href="/pubmed/15598687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15598687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.shaw.2011.e566">Shaw ND, Seminara SB, Welt CK, Au MG, Plummer L, Hughes VA, Dwyer AA, Martin KA, Quinton R, Meriq V, Merino PM, Gusella JF, Crowley WF Jr, Pitteloud N, Hall JE. Expanding the phenotype and genotype of female GnRH deficiency. <span><span class="ref-journal">J. Clin. Endocrinol. Metab. </span>2011;<span class="ref-vol">96</span>:E566–76.</span> [<a href="/pmc/articles/PMC3047229/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3047229</span></a>] [<a href="/pubmed/21209029" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21209029</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.sidhoum.2014.861">Sidhoum VF, Chan YM, Lippincott MF, Balasubramanian R, Quinton R, Plummer L, Dwyer A, Pitteloud N, Hayes FJ, Hall JE, Martin KA, Boepple PA, Seminara SB. Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2014;<span class="ref-vol">99</span>:861–70.</span> [<a href="/pmc/articles/PMC3942233/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3942233</span></a>] [<a href="/pubmed/24423288" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24423288</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.spratt.1987.283">Spratt DI, Carr DB, Merriam GR, Scully RE, Rao PN, Crowley WF Jr. The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>1987;<span class="ref-vol">64</span>:283–91.</span> [<a href="/pubmed/3098771" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3098771</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.strobel.1998.213">Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. <span><span class="ref-journal">Nat Genet. </span>1998;<span class="ref-vol">18</span>:213–5.</span> [<a href="/pubmed/9500540" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9500540</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.suzuki.2015.212">Suzuki E, Izumi Y, Chiba Y, Horikawa R, Matsubara Y, Tanaka M, Ogata T, Fukami M, Naiki Y. Loss-of-function SOX10 mutation in a patient with Kallmann syndrome, hearing loss, and iris hypopigmentation. <span><span class="ref-journal">Horm Res Paediatr. </span>2015;<span class="ref-vol">84</span>:212–6.</span> [<a href="/pubmed/26228106" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26228106</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.sykiotis.2010a.3019">Sykiotis GP, Hoang XH, Avbelj M, Hayes FJ, Thambundit A, Dwyer A, Au M, Plummer L, Crowley WF Jr, Pitteloud N. Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2010a;<span class="ref-vol">95</span>:3019–27.</span> [<a href="/pmc/articles/PMC2902061/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2902061</span></a>] [<a href="/pubmed/20382682" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20382682</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.sykiotis.2010b.15140">Sykiotis GP, Plummer L, Hughes VA, Au M, Durrani S, Nayak-Young S, Dwyer AA, Quinton R, Hall JE, Gusella JF, Seminara SB, Crowley WF Jr, Pitteloud N. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2010b;<span class="ref-vol">107</span>:15140–4.</span> [<a href="/pmc/articles/PMC2930591/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2930591</span></a>] [<a href="/pubmed/20696889" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20696889</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.topaloglu.2009.354">Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, Serin A, Mungan NO, Cook JR, Ozbek MN, Imamoglu S, Akalin NS, Yuksel B, O'Rahilly S, Semple RK. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:354–8.</span> [<a href="/pmc/articles/PMC4312696/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4312696</span></a>] [<a href="/pubmed/19079066" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19079066</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.topaloglu.2012.629">Topaloglu AK, Tello JA, Kotan LD, Ozbek MN, Yilmaz MB, Erdogan S, Gurbuz F, Temiz F, Millar R, Yuksel B. Inactivating KISS1 mutation and hypogonadotropic hypogonadism. <span><span class="ref-journal">NEJM. </span>2012;<span class="ref-vol">366</span>:629–35.</span> [<a href="/pubmed/22335740" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22335740</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.tornberg.2011.11524">Tornberg J, Sykiotis GP, Keefe K, Plummer L, Hoang X, Hall JE, Quinton R, Hughes V, Seminara SB, Van Uum S, Crowley WF, Habuchi H, Kimataf K, Piteloud N, B&#x000fc;low HE. Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotropic hypogonadism. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2011;<span class="ref-vol">108</span>:11524–9.</span> [<a href="/pmc/articles/PMC3136273/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3136273</span></a>] [<a href="/pubmed/21700882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21700882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.trarbach.2010a.3491">Trarbach EB, Abreu AP, Silveira LF, Garmes HM, Baptista MT, Teles MG, Costa EM, Mohammadi M, Pitteloud N, de Mendonca BB, Latronico AC. Nonsense mutations in <em>FGF8</em> gene causing different degrees of human gonadotropin-releasing deficiency. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2010a;<span class="ref-vol">95</span>:3491–6.</span> [<a href="/pmc/articles/PMC3213864/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3213864</span></a>] [<a href="/pubmed/20463092" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20463092</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.trarbach.2010b.371">Trarbach EB, Teles MG, Costa EM, Abreu AP, Garmes HM, Guerra G Jr, Baptista MT, de Castro M, Mendonca BB, Latronico AC. Screening of autosomal gene deletions in patients with hypogonadotropic hypogonadism using multiplex ligation-dependent probe amplification: detection of a hemizygosis for the fibroblast growth factor receptor 1. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2010b;<span class="ref-vol">72</span>:371–6.</span> [<a href="/pubmed/19489874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19489874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.van_dop.1987.684">Van Dop C, Burstein S, Conte FA, Grumbach MM. Isolated gonadotropin deficiency in boys: clinical characteristics and growth. <span><span class="ref-journal">J Pediatr. </span>1987;<span class="ref-vol">111</span>:684–92.</span> [<a href="/pubmed/2889818" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2889818</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.vissers.2004.955">Vissers LE, van Ravenswaaij CM, Admiraal R, Hurst JA, de Vries BB, Janssen IM, van der Vliet WA, Huys EH, de Jong PJ, Hamel BC, Schoenmakers EF, Brunner HG, Veltman JA, van Kessel AG. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. <span><span class="ref-journal">Nat Genet. </span>2004;<span class="ref-vol">36</span>:955–7.</span> [<a href="/pubmed/15300250" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15300250</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.waldhauser.1981.71">Waldhauser F, Weissenbacher G, Frisch H, Pollak A. Pulsatile secretion of gonadotropins in early infancy. <span><span class="ref-journal">Eur J Pediatr. </span>1981;<span class="ref-vol">137</span>:71–4.</span> [<a href="/pubmed/6791927" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6791927</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.waldstreicher.1996.4388">Waldstreicher J, Seminara SB, Jameson JL, Geyer A, Nachtigall LB, Boepple PA, Holmes LB, Crowley WF Jr. The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>1996;<span class="ref-vol">81</span>:4388–95.</span> [<a href="/pubmed/8954047" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8954047</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.whitcomb.1990.3">Whitcomb RW, Crowley WF Jr. Clinical review 4: Diagnosis and treatment of isolated gonadotropin-releasing hormone deficiency in men. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>1990;<span class="ref-vol">70</span>:3–7.</span> [<a href="/pubmed/2403572" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2403572</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.xu.2011.1613">Xu N, Kim HG, Bhagavath B, Cho SG, Lee JH, Ha K, Meliciani I, Wenzel W, Podolsky RH, Chorich LP, Stackhouse KA, Grove AM, Odom LN, Ozata M, Bick DP, Sherins RJ, Kim SH, Cameron RS, Layman LC. Nasal embryonic LHRH factor (NELF) mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. <span><span class="ref-journal">Fertil Steril. </span>2011;<span class="ref-vol">95</span>:1613–20.e1.</span> [<a href="/pmc/articles/PMC3888818/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3888818</span></a>] [<a href="/pubmed/21300340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21300340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kms.REF.young.2012.707">Young J. Approach to the male patient with congenital hypogonadotropic hypogonadism. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2012;<span class="ref-vol">97</span>:707–18.</span> [<a href="/pubmed/22392951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22392951</span></a>]</div></li></ul></div></div><div id="kms.Chapter_Notes"><h2 id="_kms_Chapter_Notes_">Chapter Notes</h2><div id="kms.Author_History"><h3>Author History</h3><p>Margaret Au, MBE, MS, CGC; Massachusetts General Hospital (2010-2013)<br />Ravikumar Balasubramanian, MD, PhD (2013-present)<br />Cassandra Buck, MS, CGC; Massachusetts General Hospital (2013-2017)<br />Marissa Caudill; University of Connecticut Health Center (2007-2010)<br />William F Crowley Jr, MD (2007-present)<br />J Carl Pallais, MD, MPH; Massachusetts General Hospital (2007-2013)<br />Nelly Pitteloud, MD; Massachusetts General Hospital (2007-2013)<br />Stephanie Seminara, MD; Massachusetts General Hospital (2007-2013)</p></div><div id="kms.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>2 March 2017 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 July 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 August 2011 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> available clinically for mutations in <i>FGF8</i> causing Kallmann syndrome 6</div></li><li class="half_rhythm"><div>4 January 2011 (cd) Revision: changes in nomenclature, Tanner staging, and test availability; references added</div></li><li class="half_rhythm"><div>8 April 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 May 2007 (me) Review posted live</div></li><li class="half_rhythm"><div>1 June 2006 (jcp) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1334</span><span class="label">PMID: <a href="/pubmed/20301509" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301509</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sca-io/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mma/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1334&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1334/?report=reader">PubReader</a></li><li><a href="/books/NBK1334/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1334" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1334" style="display:none" title="Cite this Page"><div class="bk_tt">Balasubramanian R, Crowley WF Jr. Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency. 2007 May 23 [Updated 2017 Mar 2]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1334/pdf/Bookshelf_NBK1334.pdf">PDF version of this page</a> (1.1M)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#kms.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#kms.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#kms.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#kms.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#kms.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#kms.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#kms.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#kms.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#kms.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#kms.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#kms.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#kms.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=54756[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">IL17RD</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1848[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DUSP6</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=285025[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CCDC141</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2798[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GNRHR</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=389549[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FEZF1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9723[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SEMA3E</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8822[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FGF17</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10011[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SRA1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=128674[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PROKR2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2260[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FGFR1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=84634[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KISS1R</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55636[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHD7</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2796[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GNRH1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9394[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HS6ST1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3814[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KISS1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55717[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">WDR11</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=26012[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NSMF</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=558[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">AXL</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=23767[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FLRT3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6866[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TAC3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3730[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ANOS1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=81848[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SPRY4</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55703[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">POLR3B</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=60675[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PROK2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2253[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FGF8</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10371[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SEMA3A</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6870[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TACR3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1491530" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1491530" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1491530" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1491530" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31644163" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Gonadotropins</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Gonadotropins<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24456696" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Congenital hypogonadotropic hypogonadism and Kallmann syndrome in males].</a><span class="source">[Presse Med. 2014]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Congenital hypogonadotropic hypogonadism and Kallmann syndrome in males].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ghervan C, Young J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Presse Med. 2014 Feb; 43(2):152-61. Epub 2014 Jan 20.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25071724" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Reproduction, smell, and neurodevelopmental disorders: genetic defects in different hypogonadotropic hypogonadal syndromes.</a><span class="source">[Front Endocrinol (Lausanne). 2...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Reproduction, smell, and neurodevelopmental disorders: genetic defects in different hypogonadotropic hypogonadal syndromes.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Valdes-Socin H, Rubio Almanza M, Tomé Fernández-Ladreda M, Debray FG, Bours V, Beckers A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Front Endocrinol (Lausanne). 2014; 5:109. Epub 2014 Jul 9.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/15146960" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [GnRH deficiency: new insights from genetics].</a><span class="source">[J Soc Biol. 2004]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [GnRH deficiency: new insights from genetics].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kottler ML, Hamel A, Malville E, Richard N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Soc Biol. 2004; 198(1):80-7. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20363464" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.</a><span class="source">[Ann Endocrinol (Paris). 2010]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bry-Gauillard H, Trabado S, Bouligand J, Sarfati J, Francou B, Salenave S, Chanson P, Brailly-Tabard S, Guiochon-Mantel A, Young J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ann Endocrinol (Paris). 2010 May; 71(3):158-62. Epub 2010 Apr 3.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301509" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301509" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040cd775f66d18aa8df2cd">Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:28:55-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AD6C6E03F81210000000007BB029C&amp;ncbi_session=CE8AD6C6E040CD61_1979SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1334%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1334&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1334/&amp;ncbi_pagename=Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AD6C6E040CD61_1979SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>